Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3R)-N-[(2S)-1-hydroxy-6-[(3R)-3-isocyanobutanamido]hexan-2-yl]-3-isocyanobutanamide biosynthesis
-
-
PWY-8320
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)
-
-
PWY-7726
(5Z)-dodecenoate biosynthesis I
-
-
PWY0-862
(5Z)-dodecenoate biosynthesis II
-
-
PWY-7858
(7Z,10Z,13Z)-hexadecatrienoate biosynthesis
-
-
PWY-7590
(8E,10E)-dodeca-8,10-dienol biosynthesis
-
-
PWY-7654
(9Z)-tricosene biosynthesis
-
-
PWY-7035
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7216
(R)-cysteate degradation
-
-
PWY-6642
(S)-lactate fermentation to propanoate, acetate and hydrogen
-
-
PWY-8086
(S)-propane-1,2-diol degradation
-
-
PWY-7013
(S)-reticuline biosynthesis
-
-
(S)-reticuline biosynthesis I
-
-
PWY-3581
(S)-reticuline biosynthesis II
-
-
PWY-6133
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1,5-anhydrofructose degradation
-
-
PWY-6992
1-butanol autotrophic biosynthesis (engineered)
-
-
PWY-6886
1-methylpyrrolinium biosynthesis
-
-
PWY-5315
10-cis-heptadecenoyl-CoA degradation (yeast)
-
-
PWY-7337
10-trans-heptadecenoyl-CoA degradation (MFE-dependent, yeast)
-
-
PWY-7339
10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast)
-
-
PWY-7338
11-oxyandrogens biosynthesis
-
-
PWY-8202
15-epi-lipoxin biosynthesis
-
-
PWY66-393
1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3)
-
-
PWY-6361
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)
-
-
PWY-6362
1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza)
-
-
PWY-4661
1D-myo-inositol hexakisphosphate biosynthesis IV (Dictyostelium)
-
-
PWY-6372
1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)
-
-
PWY-6554
2'-deoxymugineic acid phytosiderophore biosynthesis
-
-
PWY-5912
2,3-dihydroxybenzoate biosynthesis
-
-
PWY-5901
2,4-dinitrotoluene degradation
-
-
PWY-5642
2-amino-3-hydroxycyclopent-2-enone biosynthesis
-
-
PWY-7536
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
2-carboxy-1,4-naphthoquinol biosynthesis
-
-
PWY-5837
2-deoxy-D-glucose 6-phosphate degradation
-
-
PWY-8121
2-deoxy-D-ribose degradation II
-
-
PWY-8058
2-methyl-branched fatty acid beta-oxidation
-
-
PWY-8181
2-methylpropene degradation
-
-
PWY-7778
2-nitrotoluene degradation
-
-
PWY-5641
2-oxoglutarate decarboxylation to succinyl-CoA
-
-
PWY-5084
2-oxoisovalerate decarboxylation to isobutanoyl-CoA
-
-
PWY-5046
24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)
-
-
PWY-8238
3,5-dimethoxytoluene biosynthesis
-
-
PWY-7076
3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)
-
-
CHLOROPHYLL-SYN
3,8-divinyl-chlorophyllide a biosynthesis II (anaerobic)
-
-
PWY-5531
3,8-divinyl-chlorophyllide a biosynthesis III (aerobic, light independent)
-
-
PWY-7159
3-(4-hydroxyphenyl)pyruvate biosynthesis
-
-
PWY-5886
3-dehydroquinate biosynthesis II (archaea)
-
-
PWY-6160
3-hydroxy-4-methyl-anthranilate biosynthesis I
-
-
PWY-7717
3-hydroxy-4-methyl-anthranilate biosynthesis II
-
-
PWY-7765
3-hydroxypropanoate cycle
-
-
PWY-5743
3-hydroxypropanoate/4-hydroxybutanate cycle
-
-
PWY-5789
3-methyl-branched fatty acid alpha-oxidation
-
-
PWY66-387
3-methylbutanol biosynthesis (engineered)
-
-
PWY-6871
3-phenylpropanoate degradation
-
-
P281-PWY
3-phenylpropionate degradation
-
-
3-phosphoinositide biosynthesis
-
-
PWY-6352
3-phosphoinositide degradation
-
-
PWY-6368
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis II
-
-
PWY-7282
4-aminobutanoate degradation I
-
-
PWY-6535
4-aminobutanoate degradation II
-
-
PWY-6537
4-aminobutanoate degradation III
-
-
PWY-6536
4-aminobutanoate degradation V
-
-
PWY-5022
4-ethylphenol degradation (anaerobic)
-
-
PWY-6080
4-hydroxy-2-nonenal detoxification
-
-
PWY-7112
4-hydroxybenzoate biosynthesis I (eukaryotes)
-
-
PWY-5754
4-hydroxybenzoate biosynthesis III (plants)
-
-
PWY-6435
4-nitrophenol degradation I
-
-
PWY-5487
4-nitrophenol degradation II
-
-
PWY-5488
4-oxopentanoate degradation
-
-
PWY-7948
5-aminoimidazole ribonucleotide biosynthesis I
-
-
PWY-6121
5-aminoimidazole ribonucleotide biosynthesis II
-
-
PWY-6122
5-nitroanthranilate degradation
-
-
PWY-7044
5-oxo-L-proline metabolism
-
-
PWY-7942
6-gingerol analog biosynthesis (engineered)
-
-
PWY-6920
6-hydroxymethyl-dihydropterin diphosphate biosynthesis
-
-
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I
-
-
PWY-6147
6-hydroxymethyl-dihydropterin diphosphate biosynthesis III (Chlamydia)
-
-
PWY-7539
6-hydroxymethyl-dihydropterin diphosphate biosynthesis IV (Plasmodium)
-
-
PWY-7852
7-(3-amino-3-carboxypropyl)-wyosine biosynthesis
-
-
PWY-7286
8-amino-7-oxononanoate biosynthesis I
-
-
PWY-6519
8-amino-7-oxononanoate biosynthesis IV
-
-
PWY-8203
8-oxo-(d)GTP detoxification I
-
-
PWY-6502
9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast)
-
-
PWY-7340
ABH and Lewis epitopes biosynthesis from type 1 precursor disaccharide
-
-
PWY-7832
ABH and Lewis epitopes biosynthesis from type 2 precursor disaccharide
-
-
PWY-7831
Ac/N-end rule pathway
-
-
PWY-7800
acetaldehyde biosynthesis I
-
-
PWY-6333
acetaldehyde biosynthesis II
-
-
PWY-6330
acetate and ATP formation from acetyl-CoA I
-
-
PWY0-1312
acetoacetate degradation (to acetyl CoA)
-
-
ACETOACETATE-DEG-PWY
acetone degradation I (to methylglyoxal)
-
-
PWY-5451
acetone degradation III (to propane-1,2-diol)
-
-
PWY-7466
acetyl CoA biosynthesis
-
-
acetyl-CoA biosynthesis from citrate
-
-
PWY-5172
acetyl-CoA fermentation to butanoate
-
-
PWY-5676
acetylene degradation (anaerobic)
-
-
P161-PWY
acrylonitrile degradation I
-
-
PWY-7308
acyl-CoA hydrolysis
-
-
PWY-5148
acylceramide biosynthesis and processing
-
-
PWY-8042
adenine and adenosine salvage I
-
-
P121-PWY
adenine and adenosine salvage III
-
-
PWY-6609
adenine and adenosine salvage V
-
-
PWY-6611
adenine salvage
-
-
PWY-6610
adenosine 5'-phosphoramidate biosynthesis
-
-
PWY-6794
adenosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7227
adenosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7220
adenosine nucleotides degradation I
-
-
PWY-6596
adenosine nucleotides degradation II
-
-
SALVADEHYPOX-PWY
adenosine ribonucleotides de novo biosynthesis
-
-
PWY-7219
adipate biosynthesis
-
-
PWY-8347
aerobic respiration I (cytochrome c)
-
-
PWY-3781
aerobic respiration II (cytochrome c) (yeast)
-
-
PWY-7279
aerobic respiration III (alternative oxidase pathway)
-
-
PWY-4302
aerobic toluene degradation
-
-
Aflatoxin biosynthesis
-
-
ajmaline and sarpagine biosynthesis
-
-
PWY-5301
Alanine, aspartate and glutamate metabolism
-
-
alkane biosynthesis II
-
-
PWY-7033
alkane oxidation
-
-
PWY-2724
all-trans-farnesol biosynthesis
-
-
PWY-6859
allantoin degradation
-
-
alliin metabolism
-
-
PWY-5706
allopregnanolone biosynthesis
-
-
PWY-7455
alpha-dystroglycan glycosylation
-
-
PWY-7981
alpha-linolenate metabolites biosynthesis
-
-
PWY-8398
alpha-Linolenic acid metabolism
-
-
alpha-tomatine degradation
-
-
PWY18C3-5
Amaryllidacea alkaloids biosynthesis
-
-
PWY-7826
Amino sugar and nucleotide sugar metabolism
-
-
Aminoacyl-tRNA biosynthesis
-
-
Aminobenzoate degradation
-
-
ammonia assimilation cycle I
-
-
PWY-6963
ammonia assimilation cycle II
-
-
PWY-6964
ammonia assimilation cycle III
-
-
AMMASSIM-PWY
ammonia oxidation II (anaerobic)
-
-
P303-PWY
amygdalin and prunasin degradation
-
-
PWY-6011
anaerobic energy metabolism (invertebrates, cytosol)
-
-
PWY-7383
anaerobic energy metabolism (invertebrates, mitochondrial)
-
-
PWY-7384
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
anandamide degradation
-
-
PWY6666-1
anandamide lipoxygenation
-
-
PWY-8056
anapleurotic synthesis of oxalacetate
-
-
androgen and estrogen metabolism
-
-
androgen biosynthesis
-
-
PWY66-378
androstenedione degradation I (aerobic)
-
-
PWY-6944
androstenedione degradation II (anaerobic)
-
-
PWY-8152
anteiso-branched-chain fatty acid biosynthesis
-
-
PWY-8173
apratoxin A biosynthesis
-
-
PWY-8361
arachidonate biosynthesis
-
-
arachidonate biosynthesis I (6-desaturase, lower eukaryotes)
-
-
PWY-5353
arachidonate biosynthesis IV (8-detaturase, lower eukaryotes)
-
-
PWY-7601
arachidonate biosynthesis V (8-detaturase, mammals)
-
-
PWY-7725
arachidonate metabolites biosynthesis
-
-
PWY-8397
Arachidonic acid metabolism
-
-
arachidonic acid metabolism
-
-
Arg/N-end rule pathway (eukaryotic)
-
-
PWY-7799
Arginine and proline metabolism
-
-
Arginine biosynthesis
-
-
aromatic biogenic amine degradation (bacteria)
-
-
PWY-7431
aromatic polyketides biosynthesis
-
-
PWY-6316
arsenate detoxification I
-
-
PWY-8264
arsenate detoxification II
-
-
PWY-8101
arsenate detoxification IV (mycothiol)
-
-
PWY-6421
arsenic detoxification (mammals)
-
-
PWY-4202
arsenic detoxification (plants)
-
-
PWY-8259
arsenic detoxification (yeast)
-
-
PWY-4621
arsenite to oxygen electron transfer
-
-
PWY-4521
arsenite to oxygen electron transfer (via azurin)
-
-
PWY-7429
Ascorbate and aldarate metabolism
-
-
ascorbate glutathione cycle
-
-
PWY-2261
ascorbate recycling (cytosolic)
-
-
PWY-6370
aspartate and asparagine metabolism
-
-
aspirin triggered resolvin D biosynthesis
-
-
PWY66-395
aspirin triggered resolvin E biosynthesis
-
-
PWY66-394
assimilatory sulfate reduction I
-
-
SO4ASSIM-PWY
assimilatory sulfate reduction II
-
-
SULFMETII-PWY
assimilatory sulfate reduction III
-
-
PWY-6683
assimilatory sulfate reduction IV
-
-
PWY1ZNC-1
ATP biosynthesis
-
-
PWY-7980
atromentin biosynthesis
-
-
PWY-7518
avenanthramide biosynthesis
-
-
PWY-8157
backdoor pathway of androgen biosynthesis
-
-
PWY-8200
bacterial bioluminescence
-
-
PWY-7723
baicalein degradation (hydrogen peroxide detoxification)
-
-
PWY-7214
baicalein metabolism
-
-
PWY-7212
base-degraded thiamine salvage
-
-
PWY-6899
benzoate biosynthesis I (CoA-dependent, beta-oxidative)
-
-
PWY-6443
benzoate biosynthesis III (CoA-dependent, non-beta-oxidative)
-
-
PWY-6446
benzoyl-CoA biosynthesis
-
-
PWY-6458
benzoyl-CoA degradation I (aerobic)
-
-
PWY-1361
beta-(1,4)-mannan degradation
-
-
PWY-7456
beta-1,4-D-mannosyl-N-acetyl-D-glucosamine degradation
-
-
PWY-7586
beta-alanine biosynthesis I
-
-
PWY-3981
beta-Alanine metabolism
-
-
beta-carboline biosynthesis
-
-
PWY-5877
beta-D-glucuronide and D-glucuronate degradation
-
-
PWY-7247
Betalain biosynthesis
-
-
betalamic acid biosynthesis
-
-
PWY-5394
betanidin degradation
-
-
PWY-5461
betaxanthin biosynthesis
-
-
PWY-5426
betaxanthin biosynthesis (via dopamine)
-
-
PWY-5403
Bifidobacterium shunt
-
-
P124-PWY
bile acid biosynthesis, neutral pathway
bile acids deconjugation
-
-
PWY-8135
Biosynthesis of 12-, 14- and 16-membered macrolides
-
-
Biosynthesis of ansamycins
-
-
biosynthesis of Lewis epitopes (H. pylori)
-
-
PWY-7833
Biosynthesis of secondary metabolites
-
-
Biosynthesis of siderophore group nonribosomal peptides
-
-
Biosynthesis of unsaturated fatty acids
-
-
Biosynthesis of various secondary metabolites - part 3
-
-
biotin-carboxyl carrier protein assembly
-
-
PWY0-1264
bisabolene biosynthesis (engineered)
-
-
PWY-7102
Bisphenol degradation
-
-
brassinolide biosynthesis I
-
-
PWY-699
brassinolide biosynthesis II
-
-
PWY-2582
Brassinosteroid biosynthesis
-
-
bryostatin biosynthesis
-
-
PWY-8047
bupropion degradation
-
-
PWY66-241
butanoate fermentation
-
-
butanol and isobutanol biosynthesis (engineered)
-
-
PWY-7396
C20 prostanoid biosynthesis
-
-
PWY66-374
C25,25 CDP-archaeol biosynthesis
-
-
PWY-8365
C4 and CAM-carbon fixation
-
-
C4 photosynthetic carbon assimilation cycle, NAD-ME type
-
-
PWY-7115
C4 photosynthetic carbon assimilation cycle, NADP-ME type
-
-
PWY-241
C4 photosynthetic carbon assimilation cycle, PEPCK type
-
-
PWY-7117
C5-Branched dibasic acid metabolism
-
-
caffeine degradation III (bacteria, via demethylation)
-
-
PWY-6538
Calvin-Benson-Bassham cycle
-
-
CALVIN-PWY
camalexin biosynthesis
-
-
CAMALEXIN-SYN
canavanine biosynthesis
-
-
PWY-5
canavanine degradation
-
-
PWY-31
cannabinoid biosynthesis
-
-
PWY-5140
Caprolactam degradation
-
-
capsaicin biosynthesis
-
-
PWY-5710
carbaryl degradation
-
-
PWY-8111
carbofuran degradation I
-
-
PWY-8286
carbofuran degradation II
-
-
PWY-8287
carbofuran degradation III
-
-
PWY-8288
Carbon fixation in photosynthetic organisms
-
-
Carbon fixation pathways in prokaryotes
-
-
cardiolipin biosynthesis
-
-
cardiolipin biosynthesis I
-
-
PWY-5668
cardiolipin biosynthesis II
-
-
PWY-5269
cardiolipin biosynthesis III
-
-
PWY0-1545
Carotenoid biosynthesis
-
-
carotenoid biosynthesis
-
-
carotenoid cleavage
-
-
PWY-6806
catechol degradation to 2-hydroxypentadienoate I
-
-
P183-PWY
catechol degradation to 2-hydroxypentadienoate II
-
-
PWY-5419
catecholamine biosynthesis
CDP-6-deoxy-D-gulose biosynthesis
-
-
PWY-8139
CDP-diacylglycerol biosynthesis
-
-
CDP-diacylglycerol biosynthesis I
-
-
PWY-5667
CDP-diacylglycerol biosynthesis II
-
-
PWY0-1319
CDP-diacylglycerol biosynthesis III
-
-
PWY-5981
cell-surface glycoconjugate-linked phosphocholine biosynthesis
-
-
PWY-7886
cellulose degradation
-
-
cellulose degradation II (fungi)
-
-
PWY-6788
ceramide and sphingolipid recycling and degradation (yeast)
-
-
PWY-7119
ceramide biosynthesis
-
-
ceramide de novo biosynthesis
-
-
PWY3DJ-12
ceramide degradation (generic)
-
-
PWY-6483
ceramide degradation by alpha-oxidation
-
-
PWY66-388
chitin biosynthesis
-
-
PWY-6981
chitin degradation I (archaea)
-
-
PWY-6855
chitin degradation II (Vibrio)
-
-
PWY-6902
chitin degradation III (Serratia)
-
-
PWY-7822
Chloroalkane and chloroalkene degradation
-
-
Chlorocyclohexane and chlorobenzene degradation
-
-
chlorogenic acid biosynthesis I
-
-
PWY-6039
chlorogenic acid degradation
-
-
PWY-6781
chlorpyrifos degradation
-
-
PWY-8065
cholesterol biosynthesis
-
-
cholesterol biosynthesis (algae, late side-chain reductase)
-
-
PWY-8191
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis I
-
-
PWY66-341
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
cholesterol biosynthesis III (via desmosterol)
-
-
PWY66-4
cholesterol degradation to androstenedione I (cholesterol oxidase)
-
-
PWY-6945
cholesterol degradation to androstenedione II (cholesterol dehydrogenase)
-
-
PWY-6946
cholesterol degradation to androstenedione III (anaerobic)
-
-
PWY-8151
choline biosynthesis III
-
-
PWY-3561
chondroitin biosynthesis
-
-
PWY-6566
chondroitin sulfate biosynthesis
-
-
PWY-6567
chondroitin sulfate degradation I (bacterial)
-
-
PWY-6572
chorismate biosynthesis from 3-dehydroquinate
-
-
PWY-6163
chorismate metabolism
-
-
cis-geranyl-CoA degradation
-
-
PWY-6672
cis-vaccenate biosynthesis
cis-zeatin biosynthesis
-
-
PWY-2781
Citrate cycle (TCA cycle)
-
-
CMP phosphorylation
-
-
PWY-7205
CMP-legionaminate biosynthesis I
-
-
PWY-6749
CMP-N-acetylneuraminate biosynthesis I (eukaryotes)
-
-
PWY-6138
CMP-N-acetylneuraminate biosynthesis II (bacteria)
-
-
PWY-6139
CO2 fixation in Crenarchaeota
-
-
CO2 fixation into oxaloacetate (anaplerotic)
-
-
PWYQT-4429
coenzyme A metabolism
-
-
coenzyme B biosynthesis
-
-
P241-PWY
coenzyme M biosynthesis
-
-
coenzyme M biosynthesis II
-
-
PWY-6643
complex N-linked glycan biosynthesis (plants)
-
-
PWY-7920
complex N-linked glycan biosynthesis (vertebrates)
-
-
PWY-7426
conversion of succinate to propanoate
-
-
PWY0-43
coumarin biosynthesis (via 2-coumarate)
-
-
PWY-5176
coumarins biosynthesis (engineered)
-
-
PWY-7398
creatine biosynthesis
-
-
GLYCGREAT-PWY
creatine phosphate biosynthesis
-
-
PWY-6158
crotonate fermentation (to acetate and cyclohexane carboxylate)
-
-
PWY-7401
crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA cycle (engineered)
-
-
PWY-7854
curacin A biosynthesis
-
-
PWY-8358
curcuminoid biosynthesis
-
-
PWY-6432
cuticular wax biosynthesis
-
-
PWY-282
cutin biosynthesis
-
-
PWY-321
Cutin, suberine and wax biosynthesis
-
-
Cyanoamino acid metabolism
-
-
cyanophycin metabolism
-
-
PWY-7052
cyclic electron flow
-
-
PWY-8270
cyclopropane fatty acid (CFA) biosynthesis
-
-
PWY0-541
cylindrospermopsin biosynthesis
-
-
PWY-8045
Cysteine and methionine metabolism
-
-
cytosolic NADPH production (yeast)
-
-
PWY-7268
D-Amino acid metabolism
-
-
D-arabinose degradation V
-
-
PWY-8334
D-cycloserine biosynthesis
-
-
PWY-7274
D-galactose degradation I (Leloir pathway)
-
-
PWY-6317
D-galactose degradation II
-
-
GALDEG-PWY
D-galactose degradation IV
-
-
PWY-6693
D-galactose detoxification
-
-
PWY-3821
D-glucarate degradation I
-
-
GLUCARDEG-PWY
D-glucarate degradation II
-
-
PWY-6499
D-glucuronate degradation I
-
-
PWY-5525
D-lactate to cytochrome bo oxidase electron transfer
-
-
PWY0-1565
d-mannose degradation
-
-
D-mannose degradation I
-
-
MANNCAT-PWY
D-mannose degradation II
-
-
PWY3O-1743
D-myo-inositol (1,3,4)-trisphosphate biosynthesis
-
-
PWY-6364
D-myo-inositol (1,4,5)-trisphosphate biosynthesis
-
-
PWY-6351
D-myo-inositol (1,4,5)-trisphosphate degradation
-
-
PWY-6363
D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis
-
-
PWY-6366
D-myo-inositol-5-phosphate metabolism
-
-
PWY-6367
D-sorbitol biosynthesis I
-
-
PWY-5054
D-xylose degradation to ethylene glycol (engineered)
-
-
PWY-7178
daidzein conjugates interconversion
-
-
PWY-2343
daidzin and daidzein degradation
-
-
PWY-6996
degradation of aromatic, nitrogen containing compounds
-
-
degradation of hexoses
-
-
degradation of pentoses
-
-
degradation of sugar acids
-
-
degradation of sugar alcohols
-
-
dermatan sulfate biosynthesis
-
-
PWY-6568
dermatan sulfate degradation I (bacterial)
-
-
PWY-7646
detoxification of reactive carbonyls in chloroplasts
-
-
PWY-6786
di-homo-gamma-linolenate metabolites biosynthesis
-
-
PWY-8396
di-myo-inositol phosphate biosynthesis
-
-
PWY-6664
diacylglycerol and triacylglycerol biosynthesis
-
-
TRIGLSYN-PWY
diethylphosphate degradation
-
-
PWY-5491
dimethyl sulfide degradation I
-
-
PWY-6047
dimorphecolate biosynthesis
-
-
PWY-5368
dissimilatory sulfate reduction I (to hydrogen sufide))
-
-
DISSULFRED-PWY
divinyl ether biosynthesis II
-
-
PWY-5409
docosahexaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-7053
docosahexaenoate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7606
docosahexaenoate metabolites biosynthesis
-
-
PWY-8400
dolichol and dolichyl phosphate biosynthesis
dolichyl-diphosphooligosaccharide biosynthesis
-
-
dopamine degradation
-
-
PWY6666-2
drosopterin and aurodrosopterin biosynthesis
-
-
PWY-7442
Drug metabolism - cytochrome P450
-
-
Drug metabolism - other enzymes
-
-
dTDP-beta-L-rhamnose biosynthesis
-
-
DTDPRHAMSYN-PWY
dTMP de novo biosynthesis (mitochondrial)
-
-
PWY66-385
dZTP biosynthesis
-
-
PWY-8289
ecdysone and 20-hydroxyecdysone biosynthesis
-
-
PWY-7300
enterobactin biosynthesis
-
-
Entner Doudoroff pathway
-
-
Entner-Doudoroff pathway I
-
-
PWY-8004
Entner-Doudoroff pathway II (non-phosphorylative)
-
-
NPGLUCAT-PWY
Entner-Doudoroff pathway III (semi-phosphorylative)
-
-
PWY-2221
ergosterol biosynthesis II
-
-
PWY-7154
ergothioneine biosynthesis I (bacteria)
-
-
PWY-7255
erythritol biosynthesis I
-
-
PWY-8372
erythritol biosynthesis II
-
-
PWY-8373
erythro-tetrahydrobiopterin biosynthesis I
-
-
PWY-5663
erythromycin D biosynthesis
-
-
PWY-7106
Escherichia coli serotype O:127 O antigen biosynthesis
-
-
PWY-8231
Escherichia coli serotype O:86 O antigen biosynthesis
-
-
PWY-7290
estradiol biosynthesis I (via estrone)
-
-
PWY66-380
ethanol degradation I
-
-
ETOH-ACETYLCOA-ANA-PWY
ethanol degradation II
-
-
PWY66-21
ethanol degradation III
-
-
PWY66-161
ethanol degradation IV
-
-
PWY66-162
ethanolamine utilization
-
-
PWY0-1477
ethene biosynthesis I (plants)
-
-
ETHYL-PWY
ethene biosynthesis III (microbes)
-
-
PWY-6854
ethene biosynthesis IV (engineered)
-
-
PWY-7126
ethene biosynthesis V (engineered)
-
-
PWY-7124
Ether lipid metabolism
-
-
Ethylbenzene degradation
-
-
ethylbenzene degradation (anaerobic)
-
-
PWY-481
ethylmalonyl-CoA pathway
-
-
PWY-5741
eumelanin biosynthesis
-
-
PWY-6498
even iso-branched-chain fatty acid biosynthesis
-
-
PWY-8175
farnesylcysteine salvage pathway
-
-
PWY-6577
fatty acid alpha-oxidation I (plants)
-
-
PWY-2501
fatty acid beta-oxidation I (generic)
-
-
FAO-PWY
fatty acid beta-oxidation II (plant peroxisome)
-
-
PWY-5136
fatty acid beta-oxidation IV (unsaturated, even number)
-
-
PWY-5138
fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)
-
-
PWY-6837
fatty acid beta-oxidation VI (mammalian peroxisome)
-
-
PWY66-391
fatty acid beta-oxidation VII (yeast peroxisome)
-
-
PWY-7288
Fatty acid biosynthesis
-
-
fatty acid biosynthesis initiation (mitochondria)
-
-
PWY66-429
fatty acid biosynthesis initiation (plant mitochondria)
-
-
PWY-6799
fatty acid biosynthesis initiation (type I)
-
-
PWY-5966-1
fatty acid biosynthesis initiation (type II)
-
-
PWY-4381
Fatty acid degradation
-
-
Fatty acid elongation
-
-
fatty acid elongation -- saturated
-
-
FASYN-ELONG-PWY
fatty acid salvage
-
-
PWY-7094
Fe(II) oxidation
-
-
PWY-6692
FeMo cofactor biosynthesis
-
-
PWY-7710
ferrichrome A biosynthesis
-
-
PWY-7571
firefly bioluminescence
-
-
PWY-7913
flavin biosynthesis I (bacteria and plants)
-
-
RIBOSYN2-PWY
flavin biosynthesis II (archaea)
-
-
PWY-6167
flavin biosynthesis III (fungi)
-
-
PWY-6168
Flavone and flavonol biosynthesis
-
-
flavonoid biosynthesis
-
-
PWY1F-FLAVSYN
Flavonoid biosynthesis
-
-
flavonoid biosynthesis (in equisetum)
-
-
PWY-6787
flavonoid di-C-glucosylation
-
-
PWY-7897
fluoroacetate and fluorothreonine biosynthesis
-
-
PWY-6644
folate transformations I
-
-
PWY-2201
folate transformations II (plants)
-
-
PWY-3841
folate transformations III (E. coli)
-
-
1CMET2-PWY
formaldehyde assimilation I (serine pathway)
-
-
PWY-1622
formaldehyde assimilation II (assimilatory RuMP Cycle)
-
-
PWY-1861
formaldehyde assimilation III (dihydroxyacetone cycle)
-
-
P185-PWY
formaldehyde oxidation
-
-
formaldehyde oxidation I
-
-
RUMP-PWY
formaldehyde oxidation II (glutathione-dependent)
-
-
PWY-1801
formaldehyde oxidation VII (THF pathway)
-
-
PWY-7909
formate assimilation into 5,10-methylenetetrahydrofolate
-
-
PWY-1722
formate to nitrite electron transfer
-
-
PWY0-1585
formononetin conjugates interconversion
-
-
PWY-2904
fructan biosynthesis
-
-
PWY-822
fructan degradation
-
-
PWY-862
fructose 2,6-bisphosphate biosynthesis
-
-
PWY66-423
Fructose and mannose metabolism
-
-
GABA shunt I
-
-
GLUDEG-I-PWY
GABA shunt II
-
-
PWY-8346
gala-series glycosphingolipids biosynthesis
-
-
PWY-7840
gallate degradation III (anaerobic)
-
-
P3-PWY
gamma-glutamyl cycle
-
-
PWY-4041
gamma-linolenate biosynthesis II (animals)
-
-
PWY-6000
ganglio-series glycosphingolipids biosynthesis
-
-
PWY-7836
GDP-6-deoxy-D-talose biosynthesis
-
-
PWY-5738
GDP-alpha-D-glucose biosynthesis
-
-
PWY-5661
GDP-D-perosamine biosynthesis
-
-
PWY-5739
GDP-D-rhamnose biosynthesis
-
-
GDPRHAMSYN-PWY
GDP-L-colitose biosynthesis
-
-
PWY-5740
GDP-L-fucose biosynthesis I (from GDP-D-mannose)
-
-
PWY-66
GDP-mannose biosynthesis
-
-
PWY-5659
GDP-mycosamine biosynthesis
-
-
PWY-7573
GDP-N-acetyl-alpha-D-perosamine biosynthesis
-
-
PWY-8225
GDP-N-formyl-alpha-D-perosamine biosynthesis
-
-
PWY2B4Q-2
genistein conjugates interconversion
-
-
PWY-2345
gentisate degradation I
-
-
PWY-6223
ginsenoside metabolism
-
-
gliotoxin biosynthesis
-
-
PWY-7533
globo-series glycosphingolipids biosynthesis
-
-
PWY-7838
glucocorticoid biosynthesis
-
-
PWY66-381
gluconeogenesis I
-
-
GLUCONEO-PWY
gluconeogenesis II (Methanobacterium thermoautotrophicum)
-
-
PWY-6142
gluconeogenesis III
-
-
PWY66-399
glucose and glucose-1-phosphate degradation
-
-
GLUCOSE1PMETAB-PWY
glucose degradation (oxidative)
-
-
DHGLUCONATE-PYR-CAT-PWY
Glucosinolate biosynthesis
-
-
glucosylglycerol biosynthesis
-
-
PWY-7902
glutamate and glutamine metabolism
-
-
glutamate removal from folates
-
-
PWY-2161B
glutaminyl-tRNAgln biosynthesis via transamidation
-
-
PWY-5921
glutaryl-CoA degradation
-
-
PWY-5177
glutathione biosynthesis
-
-
GLUTATHIONESYN-PWY
glutathione degradation (DUG pathway)
-
-
PWY-7559
Glutathione metabolism
-
-
glutathione metabolism
-
-
glutathione-mediated detoxification I
-
-
PWY-4061
glutathione-mediated detoxification II
-
-
PWY-6842
glutathione-peroxide redox reactions
-
-
PWY-4081
glycerol degradation I
-
-
PWY-4261
glycerol degradation to butanol
-
-
PWY-7003
glycerol-3-phosphate shuttle
-
-
PWY-6118
glycerol-3-phosphate to cytochrome bo oxidase electron transfer
-
-
PWY0-1561
glycerol-3-phosphate to fumarate electron transfer
-
-
PWY0-1582
glycerol-3-phosphate to hydrogen peroxide electron transport
-
-
PWY0-1591
Glycerolipid metabolism
-
-
glycerophosphodiester degradation
-
-
PWY-6952
Glycerophospholipid metabolism
-
-
glycine betaine biosynthesis
-
-
glycine betaine biosynthesis IV (from glycine)
-
-
P541-PWY
glycine betaine biosynthesis V (from glycine)
-
-
PWY-6004
glycine betaine degradation I
-
-
PWY-3661
glycine betaine degradation II (mammalian)
-
-
PWY-3661-1
glycine betaine degradation III
-
-
PWY-8325
glycine biosynthesis I
-
-
GLYSYN-PWY
glycine biosynthesis II
-
-
GLYCINE-SYN2-PWY
glycine biosynthesis IV
-
-
GLYSYN-THR-PWY
glycine cleavage
-
-
GLYCLEAV-PWY
glycine degradation (reductive Stickland reaction)
-
-
PWY-8015
Glycine, serine and threonine metabolism
-
-
glycogen biosynthesis
-
-
glycogen biosynthesis I (from ADP-D-Glucose)
-
-
GLYCOGENSYNTH-PWY
glycogen biosynthesis II (from UDP-D-Glucose)
-
-
PWY-5067
glycogen biosynthesis III (from alpha-maltose 1-phosphate)
-
-
PWY-7900
glycogen degradation I
-
-
GLYCOCAT-PWY
glycogen degradation II
-
-
PWY-5941
glycolipid desaturation
-
-
PWY-782
Glycolysis / Gluconeogenesis
-
-
glycolysis I (from glucose 6-phosphate)
-
-
GLYCOLYSIS
glycolysis II (from fructose 6-phosphate)
-
-
PWY-5484
glycolysis III (from glucose)
-
-
ANAGLYCOLYSIS-PWY
glycolysis IV
-
-
PWY-1042
glycolysis V (Pyrococcus)
-
-
P341-PWY
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
-
-
Glycosaminoglycan biosynthesis - heparan sulfate / heparin
-
-
Glycosaminoglycan biosynthesis - keratan sulfate
-
-
Glycosaminoglycan degradation
-
-
glycosaminoglycan-protein linkage region biosynthesis
-
-
PWY-6557
Glycosphingolipid biosynthesis - ganglio series
-
-
Glycosphingolipid biosynthesis - globo and isoglobo series
-
-
Glycosphingolipid biosynthesis - lacto and neolacto series
-
-
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
-
-
Glyoxylate and dicarboxylate metabolism
-
-
glyoxylate assimilation
-
-
PWY-5744
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
gondoate biosynthesis (anaerobic)
-
-
PWY-7663
gossypol biosynthesis
-
-
PWY-5773
guadinomine B biosynthesis
-
-
PWY-7693
guaiacol biosynthesis
-
-
PWY18C3-23
guanine and guanosine salvage I
-
-
PWY-6620
guanine and guanosine salvage II
-
-
PWY-6599
guanosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7226
guanosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7222
guanosine nucleotides degradation I
-
-
PWY-6607
guanosine nucleotides degradation II
-
-
PWY-6606
guanosine nucleotides degradation III
-
-
PWY-6608
guanosine ribonucleotides de novo biosynthesis
-
-
PWY-7221
H. pylori 26695 O-antigen biosynthesis
-
-
PWY2DNV-5
heme b biosynthesis I (aerobic)
-
-
HEME-BIOSYNTHESIS-II
heme b biosynthesis II (oxygen-independent)
-
-
HEMESYN2-PWY
heme b biosynthesis IV (Gram-positive bacteria)
-
-
PWY-7766
heme b biosynthesis V (aerobic)
-
-
HEME-BIOSYNTHESIS-II-1
heme degradation I
-
-
PWY-5874
heparan sulfate biosynthesis
-
-
PWY-6558
heparan sulfate degradation
-
-
PWY-7651
heparin degradation
-
-
PWY-7644
heterolactic fermentation
-
-
P122-PWY
histamine biosynthesis
-
-
PWY-6173
histamine degradation
-
-
PWY-6181
homocysteine and cysteine interconversion
-
-
PWY-801
homoglutathione biosynthesis
-
-
PWY-6840
homospermidine biosynthesis I
-
-
PWY-5907
homospermidine biosynthesis II
-
-
PWY-8149
hyaluronan degradation
-
-
PWY-7645
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
hydrogen to fumarate electron transfer
-
-
PWY0-1576
hydroxycinnamic acid serotonin amides biosynthesis
-
-
PWY-5473
hydroxycinnamic acid tyramine amides biosynthesis
-
-
PWY-5474
hydroxylated fatty acid biosynthesis (plants)
-
-
PWY-6433
hypoglycin biosynthesis
-
-
PWY-5826
hypotaurine degradation
-
-
PWY-7387
i antigen and I antigen biosynthesis
-
-
PWY-7837
icosapentaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-6958
icosapentaenoate biosynthesis II (6-desaturase, mammals)
-
-
PWY-7049
icosapentaenoate biosynthesis III (8-desaturase, mammals)
-
-
PWY-7724
icosapentaenoate biosynthesis V (8-desaturase, lower eukaryotes)
-
-
PWY-7602
icosapentaenoate metabolites biosynthesis
-
-
PWY-8399
incomplete reductive TCA cycle
-
-
P42-PWY
Indole alkaloid biosynthesis
-
-
indole glucosinolate activation (intact plant cell)
-
-
PWYQT-4477
indole-3-acetate biosynthesis II
-
-
PWY-581
indole-3-acetate biosynthesis III (bacteria)
-
-
PWY-3161
indole-3-acetate biosynthesis IV (bacteria)
-
-
PWY-5025
indole-3-acetate biosynthesis VI (bacteria)
-
-
TRPIAACAT-PWY
inosine 5'-phosphate degradation
-
-
PWY-5695
inosine-5'-phosphate biosynthesis I
-
-
PWY-6123
inosine-5'-phosphate biosynthesis II
-
-
PWY-6124
inosine-5'-phosphate biosynthesis III
-
-
PWY-7234
inositol diphosphates biosynthesis
-
-
PWY-6369
Inositol phosphate metabolism
-
-
Insect hormone biosynthesis
-
-
iron reduction and absorption
-
-
PWY-5934
isoleucine metabolism
-
-
isoprene biosynthesis II (engineered)
-
-
PWY-7391
isoprenoid biosynthesis
-
-
isopropanol biosynthesis (engineered)
-
-
PWY-6876
Isoquinoline alkaloid biosynthesis
-
-
itaconate biosynthesis I
-
-
PWY-5750
itaconate degradation
-
-
PWY-5749
jadomycin biosynthesis
-
-
PWY-6679
jasmonic acid biosynthesis
-
-
PWY-735
juniperonate biosynthesis
-
-
PWY-7619
justicidin B biosynthesis
-
-
PWY-6824
juvenile hormone III biosynthesis I
-
-
PWY-6575
juvenile hormone III biosynthesis II
-
-
PWY-6650
ketogenesis
-
-
PWY66-367
L-alanine biosynthesis I
-
-
ALANINE-VALINESYN-PWY
L-alanine biosynthesis II
-
-
ALANINE-SYN2-PWY
L-alanine degradation II (to D-lactate)
-
-
ALACAT2-PWY
L-alanine degradation III
-
-
ALANINE-DEG3-PWY
L-alanine degradation IV
-
-
PWY1-2
L-alanine degradation V (oxidative Stickland reaction)
-
-
PWY-8189
L-alanine degradation VI (reductive Stickland reaction)
-
-
PWY-8188
L-arabinose degradation II
-
-
PWY-5515
L-arginine biosynthesis I (via L-ornithine)
-
-
ARGSYN-PWY
L-arginine biosynthesis II (acetyl cycle)
-
-
ARGSYNBSUB-PWY
L-arginine biosynthesis III (via N-acetyl-L-citrulline)
-
-
PWY-5154
L-arginine biosynthesis IV (archaea)
-
-
PWY-7400
L-arginine degradation I (arginase pathway)
-
-
ARGASEDEG-PWY
L-arginine degradation II (AST pathway)
-
-
AST-PWY
L-arginine degradation V (arginine deiminase pathway)
-
-
ARGDEGRAD-PWY
L-arginine degradation VI (arginase 2 pathway)
-
-
ARG-PRO-PWY
L-arginine degradation VII (arginase 3 pathway)
-
-
ARG-GLU-PWY
L-arginine degradation X (arginine monooxygenase pathway)
-
-
ARGDEG-V-PWY
L-arginine degradation XIII (reductive Stickland reaction)
-
-
PWY-8187
L-arginine degradation XIV (oxidative Stickland reaction)
-
-
PWY-6344
L-ascorbate biosynthesis IV (animals, D-glucuronate pathway)
-
-
PWY3DJ-35471
L-ascorbate biosynthesis VI (plants, myo-inositol pathway)
-
-
PWY-8142
L-ascorbate biosynthesis VIII (engineered pathway)
-
-
PWY-7165
L-ascorbate degradation II (bacterial, aerobic)
-
-
PWY-6961
L-ascorbate degradation III
-
-
PWY-6960
L-asparagine biosynthesis I
-
-
ASPARAGINE-BIOSYNTHESIS
L-asparagine biosynthesis III (tRNA-dependent)
-
-
PWY490-4
L-asparagine degradation I
-
-
ASPARAGINE-DEG1-PWY
L-asparagine degradation III (mammalian)
-
-
ASPARAGINE-DEG1-PWY-1
L-aspartate biosynthesis
-
-
ASPARTATESYN-PWY
L-aspartate degradation I
-
-
ASPARTATE-DEG1-PWY
L-aspartate degradation II (aerobic)
-
-
PWY-8291
L-aspartate degradation III (anaerobic)
-
-
PWY-8294
L-citrulline biosynthesis
-
-
CITRULBIO-PWY
L-citrulline degradation
-
-
CITRULLINE-DEG-PWY
L-cysteine biosynthesis I
-
-
CYSTSYN-PWY
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-cysteine biosynthesis IX (Trichomonas vaginalis)
-
-
PWY-8010
L-cysteine biosynthesis VI (reverse transsulfuration)
-
-
PWY-I9
L-cysteine biosynthesis VII (from S-sulfo-L-cysteine)
-
-
PWY-7870
L-cysteine degradation I
-
-
CYSTEINE-DEG-PWY
L-cysteine degradation III
-
-
PWY-5329
L-dopa and L-dopachrome biosynthesis
-
-
PWY-6481
L-dopa degradation I (mammalian)
-
-
PWY-6334
L-dopa degradation II (bacterial)
-
-
PWY-8110
L-glutamate biosynthesis I
-
-
GLUTSYN-PWY
L-glutamate degradation I
-
-
GLUTAMATE-DEG1-PWY
L-glutamate degradation II
-
-
GLUTDEG-PWY
L-glutamate degradation IX (via 4-aminobutanoate)
-
-
PWY0-1305
L-glutamate degradation V (via hydroxyglutarate)
-
-
P162-PWY
L-glutamate degradation VI (to pyruvate)
-
-
PWY-5087
L-glutamate degradation XI (reductive Stickland reaction)
-
-
PWY-8190
L-glutamine biosynthesis I
-
-
GLNSYN-PWY
L-glutamine degradation I
-
-
GLUTAMINDEG-PWY
L-histidine degradation I
-
-
HISDEG-PWY
L-histidine degradation II
-
-
PWY-5028
L-histidine degradation III
-
-
PWY-5030
L-histidine degradation V
-
-
PWY-5031
L-histidine degradation VI
-
-
HISHP-PWY
L-isoleucine biosynthesis I (from threonine)
-
-
ILEUSYN-PWY
L-isoleucine biosynthesis II
-
-
PWY-5101
L-isoleucine biosynthesis III
-
-
PWY-5103
L-isoleucine biosynthesis IV
-
-
PWY-5104
L-isoleucine biosynthesis V
-
-
PWY-5108
L-isoleucine degradation I
-
-
ILEUDEG-PWY
L-isoleucine degradation II
-
-
PWY-5078
L-isoleucine degradation III (oxidative Stickland reaction)
-
-
PWY-8184
L-lactaldehyde degradation
-
-
L-leucine biosynthesis
-
-
LEUSYN-PWY
L-leucine degradation I
-
-
LEU-DEG2-PWY
L-leucine degradation III
-
-
PWY-5076
L-leucine degradation IV (reductive Stickland reaction)
-
-
PWY-7767
L-leucine degradation V (oxidative Stickland reaction)
-
-
PWY-8185
L-lysine biosynthesis IV
-
-
LYSINE-AMINOAD-PWY
L-lysine biosynthesis V
-
-
PWY-3081
L-lysine degradation II (L-pipecolate pathway)
-
-
PWY66-425
L-lysine degradation V
-
-
PWY-5283
L-lysine degradation XI
-
-
LYSINE-DEG1-PWY
L-lysine fermentation to acetate and butanoate
-
-
P163-PWY
L-methionine biosynthesis I
-
-
HOMOSER-METSYN-PWY
L-methionine biosynthesis III
-
-
HSERMETANA-PWY
L-methionine degradation I (to L-homocysteine)
-
-
METHIONINE-DEG1-PWY
L-methionine degradation III
-
-
PWY-5082
L-methionine salvage from L-homocysteine
-
-
ADENOSYLHOMOCYSCAT-PWY
L-Ndelta-acetylornithine biosynthesis
-
-
PWY-6922
L-nicotianamine biosynthesis
-
-
PWY-5957
L-ornithine biosynthesis I
-
-
GLUTORN-PWY
L-ornithine biosynthesis II
-
-
ARGININE-SYN4-PWY
L-ornithine degradation I (L-proline biosynthesis)
-
-
ORN-AMINOPENTANOATE-CAT-PWY
L-phenylalanine biosynthesis I
-
-
PHESYN
L-phenylalanine degradation I (aerobic)
-
-
PHENYLALANINE-DEG1-PWY
L-phenylalanine degradation II (anaerobic)
-
-
ANAPHENOXI-PWY
L-phenylalanine degradation III
-
-
PWY-5079
L-phenylalanine degradation IV (mammalian, via side chain)
-
-
PWY-6318
L-phenylalanine degradation V
-
-
PWY-7158
L-phenylalanine degradation VI (reductive Stickland reaction)
-
-
PWY-8014
L-proline biosynthesis I (from L-glutamate)
-
-
PROSYN-PWY
L-proline biosynthesis II (from arginine)
-
-
PWY-4981
L-proline biosynthesis III (from L-ornithine)
-
-
PWY-3341
L-proline biosynthesis IV
-
-
PWY-4281
L-selenocysteine biosynthesis I (bacteria)
-
-
PWY0-901
L-selenocysteine biosynthesis II (archaea and eukaryotes)
-
-
PWY-6281
L-serine biosynthesis I
-
-
SERSYN-PWY
L-serine biosynthesis II
-
-
PWY-8011
L-threonine degradation I
-
-
PWY-5437
L-threonine degradation III (to methylglyoxal)
-
-
THRDLCTCAT-PWY
L-threonine degradation IV
-
-
PWY-5436
L-tryptophan degradation I (via anthranilate)
-
-
TRPCAT-PWY
L-tryptophan degradation IV (via indole-3-lactate)
-
-
TRPKYNCAT-PWY
L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5651
L-tryptophan degradation V (side chain pathway)
-
-
PWY-3162
L-tryptophan degradation VI (via tryptamine)
-
-
PWY-3181
L-tryptophan degradation VIII (to tryptophol)
-
-
PWY-5081
L-tryptophan degradation X (mammalian, via tryptamine)
-
-
PWY-6307
L-tryptophan degradation XI (mammalian, via kynurenine)
-
-
PWY-6309
L-tryptophan degradation XIII (reductive Stickland reaction)
-
-
PWY-8017
L-tyrosine biosynthesis I
-
-
TYRSYN
L-tyrosine biosynthesis IV
-
-
PWY-6134
L-tyrosine degradation I
-
-
TYRFUMCAT-PWY
L-tyrosine degradation II
-
-
PWY-5151
L-tyrosine degradation III
-
-
PWY3O-4108
L-tyrosine degradation IV (to 4-methylphenol)
-
-
PWY-7514
L-tyrosine degradation V (reductive Stickland reaction)
-
-
PWY-8016
L-valine biosynthesis
-
-
VALSYN-PWY
L-valine degradation I
-
-
VALDEG-PWY
L-valine degradation II
-
-
PWY-5057
L-valine degradation III (oxidative Stickland reaction)
-
-
PWY-8183
lactate fermentation to acetate, CO2 and hydrogen (Desulfovibrionales)
-
-
PWY-8377
lacto-series glycosphingolipids biosynthesis
-
-
PWY-7839
lanosterol biosynthesis
-
-
PWY-6132
leukotriene biosynthesis
-
-
PWY66-375
Limonene and pinene degradation
-
-
limonene degradation IV (anaerobic)
-
-
PWY-8029
linamarin degradation
-
-
PWY-3121
linear furanocoumarin biosynthesis
-
-
PWY-5365
linoleate biosynthesis I (plants)
-
-
PWY-5995
linoleate biosynthesis II (animals)
-
-
PWY-6001
linoleate metabolites biosynthesis
-
-
PWY-8395
Linoleic acid metabolism
-
-
linustatin bioactivation
-
-
PWY-7091
lipid A-core biosynthesis (E. coli K-12)
-
-
LIPA-CORESYN-PWY
lipid IVA biosynthesis (2,3-diamino-2,3-dideoxy-D-glucopyranose-containing)
-
-
PWY2B4Q-4
lipid IVA biosynthesis (E. coli)
-
-
NAGLIPASYN-PWY
lipid IVA biosynthesis (generic)
-
-
PWY-8283
lipid IVA biosynthesis (H. pylori)
-
-
PWYI-14
lipid IVA biosynthesis (P. gingivalis)
-
-
PWY-8245
lipid IVA biosynthesis (P. putida)
-
-
PWY-8073
lipid IVA biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY2G6Z-2
lipoate biosynthesis and incorporation I
-
-
PWY0-501
lipoate biosynthesis and incorporation II
-
-
PWY0-1275
lipoate biosynthesis and incorporation III (Bacillus)
-
-
PWY-6987
lipoate biosynthesis and incorporation IV (yeast)
-
-
PWY-7382
lipoate biosynthesis and incorporation V (mammals)
-
-
PWY0-501-1
Lipoic acid metabolism
-
-
Lipopolysaccharide biosynthesis
-
-
lipoxin biosynthesis
-
-
PWY66-392
long chain fatty acid ester synthesis (engineered)
-
-
PWY-6873
long-chain fatty acid activation
-
-
PWY-5143
lotaustralin degradation
-
-
PWY-6002
luteolin triglucuronide degradation
-
-
PWY-7445
macrolide antibiotic biosynthesis
-
-
malate/L-aspartate shuttle pathway
-
-
MALATE-ASPARTATE-SHUTTLE-PWY
manganese oxidation I
-
-
PWY-6591
mannitol biosynthesis
-
-
PWY-3881
mannitol degradation II
-
-
PWY-3861
Mannose type O-glycan biosynthesis
-
-
maresin biosynthesis
-
-
PWY-8356
matairesinol biosynthesis
-
-
PWY-5466
melatonin degradation I
-
-
PWY-6398
melatonin degradation II
-
-
PWY-6399
melibiose degradation
-
-
PWY0-1301
metabolism of amino sugars and derivatives
-
-
metabolism of disaccharids
-
-
Metabolism of xenobiotics by cytochrome P450
-
-
Methanobacterium thermoautotrophicum biosynthetic metabolism
-
-
PWY-6146
methanofuran biosynthesis
-
-
PWY-5254
methanogenesis from acetate
-
-
METH-ACETATE-PWY
methanol oxidation to formaldehyde IV
-
-
PWY-5506
methiin metabolism
-
-
PWY-7614
methionine metabolism
-
-
methyl indole-3-acetate interconversion
-
-
PWY-6303
methyl ketone biosynthesis (engineered)
-
-
PWY-7007
methyl parathion degradation
-
-
PWY-5489
methyl phomopsenoate biosynthesis
-
-
PWY-7721
methyl tert-butyl ether degradation
-
-
PWY-7779
methylglyoxal degradation
-
-
methylglyoxal degradation I
-
-
PWY-5386
methylglyoxal degradation III
-
-
PWY-5453
methylglyoxal degradation VIII
-
-
PWY-5386-1
methylsalicylate degradation
-
-
PWY18C3-24
methylwyosine biosynthesis
-
-
PWY-7285
mevalonate degradation
-
-
PWY-5074
mevalonate metabolism
-
-
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
mevalonate pathway II (haloarchaea)
-
-
PWY-6174
mevalonate pathway III (Thermoplasma)
-
-
PWY-7524
mevalonate pathway IV (archaea)
-
-
PWY-8125
Microbial metabolism in diverse environments
-
-
mineralocorticoid biosynthesis
-
-
PWY66-382
mitochondrial L-carnitine shuttle
-
-
PWY-6111
mitochondrial NADPH production (yeast)
-
-
PWY-7269
mixed acid fermentation
-
-
FERMENTATION-PWY
monoacylglycerol metabolism (yeast)
-
-
PWY-7420
Monobactam biosynthesis
-
-
mRNA capping I
-
-
PWY-7375
mucin core 1 and core 2 O-glycosylation
-
-
PWY-7433
mucin core 3 and core 4 O-glycosylation
-
-
PWY-7435
Mucin type O-glycan biosynthesis
-
-
mupirocin biosynthesis
-
-
PWY-8012
muropeptide degradation
-
-
PWY0-1546
mycobactin biosynthesis
-
-
PWY185E-1
mycolate biosynthesis
-
-
PWYG-321
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis
-
-
PWY-6397
mycothiol biosynthesis
-
-
PWY1G-0
myo-inositol biosynthesis
N-3-oxalyl-L-2,3-diaminopropanoate biosynthesis
-
-
PWY-8071
N-acetylneuraminate and N-acetylmannosamine degradation I
-
-
PWY0-1324
N-acetylneuraminate and N-acetylmannosamine degradation II
-
-
PWY-7581
N-Glycan biosynthesis
-
-
N-hydroxy-L-pipecolate biosynthesis
-
-
PWY-7861
NAD biosynthesis from nicotinamide
-
-
NAD-BIOSYNTHESIS-III
NAD phosphorylation and dephosphorylation
-
-
NADPHOS-DEPHOS-PWY
NAD salvage (plants)
-
-
PWY-5381
NAD salvage pathway I (PNC VI cycle)
-
-
PYRIDNUCSAL-PWY
NAD salvage pathway II (PNC IV cycle)
-
-
PWY-7761
NAD salvage pathway III (to nicotinamide riboside)
-
-
NAD-BIOSYNTHESIS-II
NAD salvage pathway IV (from nicotinamide riboside)
-
-
PWY3O-4106
NAD salvage pathway V (PNC V cycle)
-
-
PWY3O-4107
NAD(P)/NADPH interconversion
-
-
PWY-5083
NADH to cytochrome bd oxidase electron transfer I
-
-
PWY0-1334
NADH to cytochrome bo oxidase electron transfer I
-
-
PWY0-1335
NADH to cytochrome bo oxidase electron transfer II
-
-
PWY0-1567
NADH to fumarate electron transfer
-
-
PWY0-1336
NADPH to cytochrome c oxidase via plastocyanin
-
-
PWY-8271
Naphthalene degradation
-
-
naringenin biosynthesis (engineered)
-
-
PWY-7397
neolacto-series glycosphingolipids biosynthesis
-
-
PWY-7841
neolinustatin bioactivation
-
-
PWY-7092
Neomycin, kanamycin and gentamicin biosynthesis
-
-
neurosporaxanthin biosynthesis
-
-
PWY-6681
Nicotinate and nicotinamide metabolism
-
-
nicotine degradation I (pyridine pathway)
-
-
P181-PWY
nicotine degradation IV
-
-
PWY66-201
nicotine degradation V
-
-
PWY66-221
nitrate reduction I (denitrification)
-
-
DENITRIFICATION-PWY
nitrate reduction IX (dissimilatory)
-
-
PWY0-1581
nitrate reduction VII (denitrification)
-
-
PWY-6748
nitrate reduction X (dissimilatory, periplasmic)
-
-
PWY0-1584
nitric oxide biosynthesis II (mammals)
-
-
PWY-4983
nitrifier denitrification
-
-
PWY-7084
nitrite-dependent anaerobic methane oxidation
-
-
PWY-6523
nitrogen remobilization from senescing leaves
-
-
PWY-6549
Nitrotoluene degradation
-
-
nocardicin A biosynthesis
-
-
PWY-7797
noradrenaline and adrenaline degradation
-
-
PWY-6342
Novobiocin biosynthesis
-
-
nucleoside and nucleotide degradation (archaea)
-
-
PWY-5532
O-antigen biosynthesis
-
-
O-antigen building blocks biosynthesis (E. coli)
-
-
OANTIGEN-PWY
O-Antigen nucleotide sugar biosynthesis
-
-
o-diquinones biosynthesis
-
-
PWY-6752
octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)
-
-
PWY-7388
octopamine biosynthesis
-
-
PWY-7297
odd iso-branched-chain fatty acid biosynthesis
-
-
PWY-8174
oleandomycin activation/inactivation
-
-
PWY-6972
oleate beta-oxidation
-
-
PWY0-1337
oleate beta-oxidation (isomerase-dependent, yeast)
-
-
PWY-7291
oleate biosynthesis I (plants)
-
-
PWY-5147
oleate biosynthesis II (animals and fungi)
-
-
PWY-5996
oleate biosynthesis III (cyanobacteria)
-
-
PWY-7587
oleate biosynthesis IV (anaerobic)
-
-
PWY-7664
One carbon pool by folate
-
-
ophthalmate biosynthesis
-
-
PWY-8043
Other glycan degradation
-
-
Other types of O-glycan biosynthesis
-
-
oxidative decarboxylation of pyruvate
-
-
Oxidative phosphorylation
-
-
oxidative phosphorylation
-
-
palmitate biosynthesis
-
-
palmitate biosynthesis I (type I fatty acid synthase)
-
-
PWY-5994
palmitate biosynthesis II (type II fatty acid synthase)
-
-
PWY-5971
palmitate biosynthesis III
-
-
PWY-8279
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate)
-
-
PWY-6282
palmitoleate biosynthesis III (cyanobacteria)
-
-
PWY-7589
palmitoleate biosynthesis IV (fungi and animals)
-
-
PWY3O-1801
palmitoyl ethanolamide biosynthesis
-
-
PWY-8055
Pantothenate and CoA biosynthesis
-
-
pantothenate biosynthesis
-
-
paraoxon degradation
-
-
PWY-5490
parathion degradation
-
-
PARATHION-DEGRADATION-PWY
partial TCA cycle (obligate autotrophs)
-
-
PWY-5913
pederin biosynthesis
-
-
PWY-8049
Penicillin and cephalosporin biosynthesis
-
-
pentachlorophenol degradation
-
-
PCPDEG-PWY
pentacyclic triterpene biosynthesis
-
-
PWY-7251
Pentose and glucuronate interconversions
-
-
Pentose phosphate pathway
-
-
pentose phosphate pathway
-
-
pentose phosphate pathway (non-oxidative branch) I
-
-
NONOXIPENT-PWY
pentose phosphate pathway (non-oxidative branch) II
-
-
PWY-8178
pentose phosphate pathway (oxidative branch) I
-
-
OXIDATIVEPENT-PWY
pentose phosphate pathway (partial)
-
-
P21-PWY
peptido-conjugates in tissue regeneration biosynthesis
-
-
PWY-8355
Peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis I (meso-diaminopimelate containing)
-
-
PEPTIDOGLYCANSYN-PWY
peptidoglycan biosynthesis II (staphylococci)
-
-
PWY-5265
peptidoglycan biosynthesis III (mycobacteria)
-
-
PWY-6385
peptidoglycan biosynthesis IV (Enterococcus faecium)
-
-
PWY-6471
peptidoglycan biosynthesis V (beta-lactam resistance)
-
-
PWY-6470
peptidoglycan maturation (meso-diaminopimelate containing)
-
-
PWY0-1586
peptidoglycan recycling I
-
-
PWY0-1261
peptidoglycan recycling II
-
-
PWY-7883
phenylacetate degradation (aerobic)
-
-
phenylacetate degradation I (aerobic)
-
-
PWY0-321
Phenylalanine metabolism
-
-
phenylalanine metabolism
-
-
Phenylalanine, tyrosine and tryptophan biosynthesis
-
-
phenylethanol biosynthesis
-
-
PWY-5751
phenylethylamine degradation I
-
-
2PHENDEG-PWY
phenylpropanoid biosynthesis
-
-
PWY-361
Phenylpropanoid biosynthesis
-
-
phenylpropanoid biosynthesis
-
-
phenylpropanoids methylation (ice plant)
-
-
PWY-7498
pheomelanin biosynthesis
-
-
PWY-7917
phloridzin biosynthesis
-
-
PWY-6515
phosphate acquisition
-
-
PWY-6348
phosphatidate biosynthesis (yeast)
-
-
PWY-7411
phosphatidate metabolism, as a signaling molecule
-
-
PWY-7039
phosphatidylcholine acyl editing
-
-
PWY-6803
phosphatidylcholine biosynthesis I
-
-
PWY3O-450
phosphatidylcholine biosynthesis II
-
-
PWY4FS-2
phosphatidylcholine biosynthesis VI
-
-
PWY-6826
phosphatidylcholine biosynthesis VII
-
-
PWY-7470
phosphatidylcholine resynthesis via glycerophosphocholine
-
-
PWY-7367
phosphatidylethanolamine biosynthesis II
-
-
PWY4FS-6
phosphatidylethanolamine biosynthesis III
-
-
PWY-6273
phosphatidylethanolamine bioynthesis
-
-
phosphatidylglycerol biosynthesis I
-
-
PWY4FS-7
phosphatidylglycerol biosynthesis II
-
-
PWY4FS-8
phosphatidylinositol biosynthesis I (bacteria)
-
-
PWY-6580
phosphatidylinositol biosynthesis II (eukaryotes)
-
-
PWY-7625
phosphatidylserine and phosphatidylethanolamine biosynthesis I
-
-
PWY-5669
phosphatidylserine biosynthesis I
-
-
PWY-7501
phosphatidylserine biosynthesis II
-
-
PWY-7506
phospholipases
-
-
LIPASYN-PWY
phospholipid desaturation
-
-
PWY-762
phospholipid remodeling (phosphatidate, yeast)
-
-
PWY-7417
phospholipid remodeling (phosphatidylcholine, yeast)
-
-
PWY-7416
phospholipid remodeling (phosphatidylethanolamine, yeast)
-
-
PWY-7409
Phosphonate and phosphinate metabolism
-
-
phosphopantothenate biosynthesis I
-
-
PANTO-PWY
phosphopantothenate biosynthesis II
-
-
PWY-3961
photorespiration I
-
-
PWY-181
photorespiration II
-
-
PWY-8362
photorespiration III
-
-
PWY-8363
photosynthesis light reactions
-
-
PWY-101
photosynthetic 3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7218
phytate degradation I
-
-
PWY-4702
phytochelatins biosynthesis
-
-
PWY-6745
phytol degradation
-
-
PWY66-389
phytosterol biosynthesis (plants)
-
-
PWY-2541
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
plasmalogen degradation
-
-
PWY-7783
plastoquinol-9 biosynthesis I
-
-
PWY-1581
platensimycin biosynthesis
-
-
PWY-8179
poly(ribitol phosphate) wall teichoic acid biosynthesis I (B. subtilis)
-
-
PWY-7815
poly(ribitol phosphate) wall teichoic acid biosynthesis II (S. aureus)
-
-
PWY-7816
poly-hydroxy fatty acids biosynthesis
-
-
PWY-6710
Polycyclic aromatic hydrocarbon degradation
-
-
polyhydroxybutanoate biosynthesis
-
-
PWY1-3
Porphyrin and chlorophyll metabolism
-
-
ppGpp metabolism
-
-
PPGPPMET-PWY
preQ0 biosynthesis
-
-
PWY-6703
Primary bile acid biosynthesis
-
-
procollagen hydroxylation and glycosylation
-
-
PWY-7894
progesterone biosynthesis
-
-
PWY-7299
proline to cytochrome bo oxidase electron transfer
-
-
PWY0-1544
propanethial S-oxide biosynthesis
-
-
PWY-5707
propanoate fermentation to 2-methylbutanoate
-
-
PWY-5109
Propanoate metabolism
-
-
propanoyl CoA degradation I
-
-
PROPIONMET-PWY
propanoyl-CoA degradation II
-
-
PWY-7574
propionate fermentation
-
-
protectin biosynthesis
-
-
PWY-8357
protective electron sinks in the thylakoid membrane (PSII to PTOX)
-
-
PWY1YI0-7
protein citrullination
-
-
PWY-4921
protein N-glycosylation (Haloferax volcanii)
-
-
PWY-7661
protein N-glycosylation initial phase (eukaryotic)
-
-
MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS
protein N-glycosylation processing phase (endoplasmic reticulum, yeast)
-
-
PWY-7918
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
protein NEDDylation
-
-
PWY-7899
protein O-mannosylation I (yeast)
-
-
PWY-7921
protein O-mannosylation II (mammals, core M1 and core M2)
-
-
PWY-7922
protein O-mannosylation III (mammals, core M3)
-
-
PWY-7979
protein O-[N-acetyl]-glucosylation
-
-
PWY-7437
protein S-nitrosylation and denitrosylation
-
-
PWY-7798
protein ubiquitination
-
-
PWY-7511
PRPP biosynthesis
-
-
PWY0-662
psilocybin biosynthesis
-
-
PWY-7936
purine deoxyribonucleosides degradation I
-
-
PWY-7179
purine deoxyribonucleosides degradation II
-
-
PWY-7179-1
purine deoxyribonucleosides salvage
-
-
PWY-7224
purine nucleobases degradation I (anaerobic)
-
-
P164-PWY
purine nucleobases degradation II (anaerobic)
-
-
PWY-5497
purine ribonucleosides degradation
-
-
PWY0-1296
putrescine biosynthesis III
-
-
PWY-46
putrescine degradation III
-
-
PWY-0
pyridoxal 5'-phosphate biosynthesis I
-
-
PYRIDOXSYN-PWY
pyridoxal 5'-phosphate salvage I
-
-
PLPSAL-PWY
pyridoxal 5'-phosphate salvage II (plants)
-
-
PWY-7204
pyrimidine deoxyribonucleosides degradation
-
-
PWY-7181
pyrimidine deoxyribonucleosides salvage
-
-
PWY-7199
pyrimidine deoxyribonucleotide phosphorylation
-
-
PWY-7197
pyrimidine deoxyribonucleotides biosynthesis from CTP
-
-
PWY-7210
pyrimidine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7184
pyrimidine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7187
pyrimidine deoxyribonucleotides de novo biosynthesis III
-
-
PWY-6545
pyrimidine deoxyribonucleotides de novo biosynthesis IV
-
-
PWY-7198
pyrimidine deoxyribonucleotides dephosphorylation
-
-
PWY-7206
Pyrimidine metabolism
-
-
pyrimidine metabolism
-
-
pyrimidine nucleobases salvage I
-
-
PWY-7183
pyrimidine nucleobases salvage II
-
-
PWY-7194
pyrimidine ribonucleosides degradation
-
-
PWY0-1295
pyrimidine ribonucleosides salvage I
-
-
PWY-7193
pyrimidine ribonucleosides salvage II
-
-
PWY-6556
pyrimidine ribonucleosides salvage III
-
-
PWY-7195
pyruvate decarboxylation to acetyl CoA I
-
-
PYRUVDEHYD-PWY
pyruvate decarboxylation to acetyl CoA II
-
-
PWY-6970
pyruvate fermentation to (R)-lactate
-
-
PWY-8274
pyruvate fermentation to (S)-lactate
-
-
PWY-5481
pyruvate fermentation to acetate II
-
-
PWY-5482
pyruvate fermentation to acetate IV
-
-
PWY-5485
pyruvate fermentation to acetate V
-
-
PWY-5537
pyruvate fermentation to acetate VI
-
-
PWY-5538
pyruvate fermentation to acetate VIII
-
-
PWY-5768
pyruvate fermentation to acetoin III
-
-
PWY3O-440
pyruvate fermentation to acetone
-
-
PWY-6588
pyruvate fermentation to butanoate
-
-
CENTFERM-PWY
pyruvate fermentation to butanol I
-
-
PWY-6583
pyruvate fermentation to butanol II (engineered)
-
-
PWY-6883
pyruvate fermentation to ethanol I
-
-
PWY-5480
pyruvate fermentation to ethanol II
-
-
PWY-5486
pyruvate fermentation to ethanol III
-
-
PWY-6587
pyruvate fermentation to hexanol (engineered)
-
-
PWY-6863
pyruvate fermentation to isobutanol (engineered)
-
-
PWY-7111
pyruvate fermentation to propanoate I
-
-
P108-PWY
pyruvate to cytochrome bo oxidase electron transfer
-
-
PWY-7544
quercetin glucoside degradation (Allium)
-
-
PWY-7133
reactive oxygen species degradation
-
-
DETOX1-PWY-1
reductive acetyl coenzyme A pathway
-
-
reductive acetyl coenzyme A pathway I (homoacetogenic bacteria)
-
-
CODH-PWY
reductive glycine pathway of autotrophic CO2 fixation
-
-
PWY-8303
reductive TCA cycle I
-
-
P23-PWY
reductive TCA cycle II
-
-
PWY-5392
resolvin D biosynthesis
-
-
PWY66-397
retinoate biosynthesis I
-
-
PWY-6872
retinol biosynthesis
-
-
PWY-6857
Riboflavin metabolism
-
-
ricinoleate biosynthesis
-
-
PWY-7618
rosmarinic acid biosynthesis I
-
-
PWY-5048
rosmarinic acid biosynthesis II
-
-
PWY-5049
roxarsone degradation I
-
-
PWY-8260
Rubisco shunt
-
-
PWY-5723
rutin degradation (plants)
-
-
PWY-7134
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine biosynthesis
-
-
PWY-8301
S-adenosyl-L-methionine biosynthesis
-
-
SAM-PWY
S-adenosyl-L-methionine salvage I
-
-
PWY-6151
S-adenosyl-L-methionine salvage II
-
-
PWY-5041
S-methyl-5'-thioadenosine degradation I
-
-
PWY-6754
S-methyl-5'-thioadenosine degradation IV
-
-
PWY0-1391
salicylate biosynthesis I
-
-
PWY-6406
salicylate biosynthesis II
-
-
PWY-8321
salidroside biosynthesis
-
-
PWY-6802
salinosporamide A biosynthesis
-
-
PWY-6627
Salmonella enterica serotype O:13 O antigen biosynthesis
-
-
PWY-8230
saponin biosynthesis II
-
-
PWY-5756
sciadonate biosynthesis
-
-
PWY-6598
scopoletin biosynthesis
-
-
PWY-6792
secologanin and strictosidine biosynthesis
-
-
PWY-5290
Secondary bile acid biosynthesis
-
-
sedoheptulose bisphosphate bypass
-
-
PWY0-1517
selenate reduction
-
-
PWY-6932
seleno-amino acid biosynthesis (plants)
-
-
PWY-6936
Selenocompound metabolism
-
-
selenocysteine biosynthesis
-
-
serotonin and melatonin biosynthesis
-
-
PWY-6030
serotonin degradation
-
-
PWY-6313
sesamin biosynthesis
-
-
PWY-5469
Sesquiterpenoid and triterpenoid biosynthesis
-
-
sitosterol degradation to androstenedione
-
-
PWY-6948
sophorosyloxydocosanoate deacetylation
-
-
SOPHOROSYLOXYDOCOSANOATE-DEG-PWY
sorbitol biosynthesis II
-
-
PWY-5530
sorgoleone biosynthesis
-
-
PWY-5987
spermidine biosynthesis I
-
-
BSUBPOLYAMSYN-PWY
spermine and spermidine degradation I
-
-
PWY-6117
spermine biosynthesis
-
-
ARGSPECAT-PWY
sphingolipid biosynthesis (mammals)
-
-
PWY-7277
sphingolipid biosynthesis (plants)
-
-
PWY-5129
sphingolipid biosynthesis (yeast)
-
-
SPHINGOLIPID-SYN-PWY
Sphingolipid metabolism
-
-
sphingomyelin metabolism
-
-
PWY3DJ-11281
sphingosine and sphingosine-1-phosphate metabolism
-
-
PWY3DJ-11470
sphingosine metabolism
-
-
Spodoptera littoralis pheromone biosynthesis
-
-
PWY-7656
sporopollenin precursors biosynthesis
-
-
PWY-6733
stachyose degradation
-
-
PWY-6527
Starch and sucrose metabolism
-
-
starch biosynthesis
-
-
PWY-622
starch degradation I
-
-
PWY-842
starch degradation III
-
-
PWY-6731
starch degradation V
-
-
PWY-6737
stearate biosynthesis I (animals)
-
-
PWY-5972
stearate biosynthesis II (bacteria and plants)
-
-
PWY-5989
stearate biosynthesis III (fungi)
-
-
PWY3O-355
stearate biosynthesis IV
-
-
PWY-8280
stellatic acid biosynthesis
-
-
PWY-7736
sterculate biosynthesis
-
-
PWY-4942
Steroid hormone biosynthesis
-
-
sterol biosynthesis (methylotrophs)
-
-
PWY-8026
sterol:steryl ester interconversion (yeast)
-
-
PWY-7424
stigma estolide biosynthesis
-
-
PWY-6453
Stilbenoid, diarylheptanoid and gingerol biosynthesis
-
-
streptomycin biosynthesis
-
-
PWY-5940
Streptomycin biosynthesis
-
-
streptorubin B biosynthesis
-
-
PWY1A0-6120
suberin monomers biosynthesis
succinate to chytochrome c oxidase via cytochrome c6
-
-
PWY1YI0-2
succinate to cytochrome bd oxidase electron transfer
-
-
PWY0-1353
succinate to cytochrome bo oxidase electron transfer
-
-
PWY0-1329
succinate to cytochrome c oxidase via plastocyanin
-
-
PWY1YI0-3
succinate to plastoquinol oxidase
-
-
PWY1YI0-8
sucrose biosynthesis I (from photosynthesis)
-
-
SUCSYN-PWY
sucrose biosynthesis II
-
-
PWY-7238
sucrose biosynthesis III
-
-
PWY-7347
sucrose degradation II (sucrose synthase)
-
-
PWY-3801
sucrose degradation III (sucrose invertase)
-
-
PWY-621
sucrose degradation IV (sucrose phosphorylase)
-
-
PWY-5384
sucrose degradation V (sucrose alpha-glucosidase)
-
-
PWY66-373
sulfate activation for sulfonation
-
-
PWY-5340
sulfated glycosaminoglycan metabolism
-
-
sulfide oxidation IV (mitochondria)
-
-
PWY-7927
sulfite oxidation II
-
-
PWY-5279
sulfite oxidation III
-
-
PWY-5278
sulfite oxidation IV (sulfite oxidase)
-
-
PWY-5326
sulfolactate degradation III
-
-
PWY-6638
sulfopterin metabolism
-
-
sulfur volatiles biosynthesis
-
-
PWY-6736
superoxide radicals degradation
-
-
DETOX1-PWY
superpathway of 5-aminoimidazole ribonucleotide biosynthesis
-
-
PWY-6277
superpathway of coenzyme A biosynthesis III (mammals)
-
-
COA-PWY-1
superpathway of fatty acid biosynthesis initiation
-
-
FASYN-INITIAL-PWY
superpathway of fermentation (Chlamydomonas reinhardtii)
-
-
PWY4LZ-257
superpathway of glucose and xylose degradation
-
-
PWY-6901
superpathway of glycolysis and the Entner-Doudoroff pathway
-
-
GLYCOLYSIS-E-D
superpathway of glyoxylate cycle and fatty acid degradation
-
-
PWY-561
superpathway of L-aspartate and L-asparagine biosynthesis
-
-
ASPASN-PWY
superpathway of methylsalicylate metabolism
-
-
PWY18C3-25
superpathway of ornithine degradation
-
-
ORNDEG-PWY
superpathway of phospholipid biosynthesis II (plants)
-
-
PHOSLIPSYN2-PWY
superpathway of photosynthetic hydrogen production
-
-
PWY-7731
superpathway of polyamine biosynthesis II
-
-
POLYAMINSYN3-PWY
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)
-
-
PWY0-166
superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis
-
-
PWY-7328
Taurine and hypotaurine metabolism
-
-
taurine biosynthesis I
-
-
PWY-5331
taurine biosynthesis II
-
-
PWY-7850
taurine biosynthesis III
-
-
PWY-8359
TCA cycle I (prokaryotic)
-
-
TCA
TCA cycle II (plants and fungi)
-
-
PWY-5690
TCA cycle III (animals)
-
-
PWY66-398
TCA cycle IV (2-oxoglutarate decarboxylase)
-
-
P105-PWY
TCA cycle V (2-oxoglutarate synthase)
-
-
PWY-6969
TCA cycle VI (Helicobacter)
-
-
REDCITCYC
TCA cycle VII (acetate-producers)
-
-
PWY-7254
TCA cycle VIII (Chlamydia)
-
-
TCA-1
teichuronic acid biosynthesis (B. subtilis 168)
-
-
PWY-7820
terminal O-glycans residues modification (via type 2 precursor disaccharide)
-
-
PWY-7434
Terpenoid backbone biosynthesis
-
-
testosterone and androsterone degradation to androstendione (aerobic)
-
-
PWY-6943
tetradecanoate biosynthesis (mitochondria)
-
-
PWY66-430
tetrahydrofolate biosynthesis I
-
-
PWY-6614
tetrahydrofolate metabolism
-
-
tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate
-
-
PWY-6613
tetrahydromonapterin biosynthesis
-
-
PWY0-1433
tetrahydropteridine recycling
-
-
PWY-8099
tetrapyrrole biosynthesis I (from glutamate)
-
-
PWY-5188
tetrapyrrole biosynthesis II (from glycine)
-
-
PWY-5189
the visual cycle I (vertebrates)
-
-
PWY-6861
theophylline degradation
-
-
PWY-6999
thiamine diphosphate salvage IV (yeast)
-
-
PWY-7356
thiamine triphosphate metabolism
-
-
PWY-7369
thioredoxin pathway
-
-
THIOREDOX-PWY
thiosulfate disproportionation IV (rhodanese)
-
-
PWY-5350
threo-tetrahydrobiopterin biosynthesis
-
-
PWY-6983
thymine degradation
-
-
PWY-6430
thyroid hormone biosynthesis
thyroid hormone metabolism I (via deiodination)
-
-
PWY-6260
thyroid hormone metabolism II (via conjugation and/or degradation)
-
-
PWY-6261
toluene degradation II (aerobic) (via 4-methylcatechol)
-
-
TOLUENE-DEG-3-OH-PWY
toluene degradation to 2-hydroxypentadienoate (via toluene-cis-diol)
-
-
TOLUENE-DEG-DIOL-PWY
toluene degradation to 2-hydroxypentadienoate I (via o-cresol)
-
-
TOLUENE-DEG-2-OH-PWY
toxoflavin biosynthesis
-
-
PWY-7991
trans, trans-farnesyl diphosphate biosynthesis
-
-
PWY-5123
trans-3-hydroxy-L-proline degradation
-
-
PWY-7515
traumatin and (Z)-3-hexen-1-yl acetate biosynthesis
-
-
PWY-5410
trehalose biosynthesis IV
-
-
PWY-2622
trehalose degradation I (low osmolarity)
-
-
TREDEGLOW-PWY
trehalose degradation II (cytosolic)
-
-
PWY0-1182
trehalose degradation IV
-
-
PWY-2722
trehalose degradation V
-
-
PWY-2723
triacylglycerol degradation
-
-
LIPAS-PWY
tRNA charging
-
-
TRNA-CHARGING-PWY
tRNA methylation (yeast)
-
-
PWY-6829
tRNA processing
-
-
PWY0-1479
tRNA splicing I
-
-
PWY-6689
tRNA splicing II
-
-
PWY-7803
Tropane, piperidine and pyridine alkaloid biosynthesis
-
-
Tryptophan metabolism
-
-
tryptophan metabolism
-
-
tunicamycin biosynthesis
-
-
PWY-7821
type I lipoteichoic acid biosynthesis (S. aureus)
-
-
PWY-7817
type IV lipoteichoic acid biosynthesis (S. pneumoniae)
-
-
PWY-7818
Ubiquinone and other terpenoid-quinone biosynthesis
-
-
UDP-alpha-D-galactofuranose biosynthesis
-
-
PWY-7622
UDP-alpha-D-glucose biosynthesis
-
-
PWY-7343
UDP-alpha-D-glucuronate biosynthesis (from myo-inositol)
-
-
PWY-4841
UDP-alpha-D-glucuronate biosynthesis (from UDP-glucose)
-
-
PWY-7346
UDP-GlcNAc biosynthesis
-
-
UDP-N-acetyl-D-galactosamine biosynthesis II
-
-
PWY-5514
UDP-N-acetyl-D-galactosamine biosynthesis III
-
-
PWY-8013
UDP-N-acetyl-D-glucosamine biosynthesis I
-
-
UDPNAGSYN-PWY
UDP-N-acetyl-D-glucosamine biosynthesis II
-
-
UDPNACETYLGALSYN-PWY
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing)
-
-
PWY-6387
UDP-N-acetylmuramoyl-pentapeptide biosynthesis II (lysine-containing)
-
-
PWY-6386
UDP-N-acetylmuramoyl-pentapeptide biosynthesis III (meso-diaminopimelate containing)
-
-
PWY-7953
ultra-long-chain fatty acid biosynthesis
-
-
PWY-8041
UMP biosynthesis I
-
-
PWY-5686
UMP biosynthesis II
-
-
PWY-7790
UMP biosynthesis III
-
-
PWY-7791
uracil degradation I (reductive)
-
-
PWY-3982
urate conversion to allantoin I
-
-
PWY-5691
urate conversion to allantoin II
-
-
PWY-7394
urate conversion to allantoin III
-
-
PWY-7849
urea degradation II
-
-
PWY-5704
UTP and CTP de novo biosynthesis
-
-
PWY-7176
UTP and CTP dephosphorylation I
-
-
PWY-7185
UTP and CTP dephosphorylation II
-
-
PWY-7177
Valine, leucine and isoleucine biosynthesis
-
-
Valine, leucine and isoleucine degradation
-
-
valproate beta-oxidation
-
-
PWY-8182
vancomycin resistance I
-
-
PWY-6454
vanillin biosynthesis I
-
-
PWY-5665
Various types of N-glycan biosynthesis
-
-
vernolate biosynthesis III
-
-
PWY-6917
very long chain fatty acid biosynthesis I
-
-
PWY-5080
very long chain fatty acid biosynthesis II
-
-
PWY-7036
vitamin B1 metabolism
-
-
Vitamin B6 metabolism
-
-
vitamin B6 metabolism
-
-
vitamin D3 biosynthesis
-
-
PWY-6076
vitamin D3 metabolism
-
-
vitamin E biosynthesis (tocopherols)
-
-
PWY-1422
wax esters biosynthesis I
-
-
PWY-5884
wax esters biosynthesis II
-
-
PWY-5885
wogonin metabolism
-
-
PWY-7213
xanthine and xanthosine salvage
-
-
SALVPURINE2-PWY
xanthohumol biosynthesis
-
-
PWY-5135
xanthommatin biosynthesis
-
-
PWY-8249
xylitol degradation I
-
-
LARABITOLUTIL-PWY
xyloglucan degradation II (exoglucanase)
-
-
PWY-6807
zymosterol biosynthesis
-
-
PWY-6074
adipate degradation
-
-
PWY-8354
bile acid biosynthesis, neutral pathway
-
-
PWY-6061
bile acid biosynthesis, neutral pathway
-
-
catecholamine biosynthesis
-
-
PWY66-301
catecholamine biosynthesis
-
-
cis-vaccenate biosynthesis
-
-
PWY-5973
cis-vaccenate biosynthesis
-
-
cyanate degradation
-
-
CYANCAT-PWY
dolichol and dolichyl phosphate biosynthesis
-
-
PWY-6129
dolichol and dolichyl phosphate biosynthesis
-
-
folate polyglutamylation
-
-
PWY-2161
folate polyglutamylation
-
-
methylaspartate cycle
-
-
PWY-6728
methylaspartate cycle
-
-
myo-inositol biosynthesis
-
-
PWY-2301
myo-inositol biosynthesis
-
-
octane oxidation
-
-
P221-PWY
suberin monomers biosynthesis
-
-
PWY-1121
suberin monomers biosynthesis
-
-
thyroid hormone biosynthesis
-
-
PWY-6241
thyroid hormone biosynthesis
-
-
urea cycle
-
-
PWY-4984
vitamin K-epoxide cycle
-
-
PWY-7999
vitamin K-epoxide cycle
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
-
brenda
-
-
brenda
-
-
brenda
expression of Notum1a first appears around the blastoderm margin prior to the onset of gastrulation
brenda
-
-
brenda
-
2.5 hpf
brenda
-
brenda
-
brenda
-
grown in taurin-free or taurine-containing medium
brenda
-
brenda
-
brenda
exposure of the fish to water-soluble fraction of crude oil produces an apparent concentration-specific increase of 3beta-hydroxysteroid dehydrogenase
brenda
high expression level in inner ear
brenda
-
brenda
-
brenda
-
-
brenda
of 36-h post-fertilization zebrafish embryos
brenda
-
Lfng is required cell autonomously in neural epithelial cells to limit the amount of neurogenesis and to maintain progenitors
brenda
-
brenda
-
brenda
-
-
brenda
-
-
brenda
more or less ubiquitously expressed from the end of gastrula through segmentation
brenda
-
-
brenda
in the zebrafish lateral line neuromasts
brenda
-
i.e. culture medium after embryos hatched out
brenda
-
-
brenda
high expression level in caudal hematopoietic tissue
brenda
-
-
brenda
-
NTPDases 1 and 2 differentially localized in
brenda
-
brenda
-
-
brenda
uroporphyrinogen III synthase forms pairs of bilateral stripes in the lateral mesoderm at the 15-somite stage. At 24 h post-fertilization, uroporphyrinogen III synthase is predominantly expressed in the intermediate cell mass (ICM) that is the major site of hematopoiesis. The expression is drastically suppressed in the bloodless mutants cloche and vlad tepes/gata 1 from 15-somite to 24hpf stages, indicating that both cloche abd vlad tepes/gata 1 are required for the induction and maitenance of uroporphyrinogen III synthase expression in intermediate cell mass
brenda
-
brenda
from 2 d or 4 d postfertilization (dpf) embryos, im:7148400 is the only MLCK isozyme in keratocytes
brenda
the enzyme is expressedin two distinct phases during the zebrafish embryogenesis. The early phase extends from late blastulation to the completion of epiboly, during which the expression occurs in the superficial layer of the embryos. The second phase of expression starts during mid-segmentation and persists until day 3, during which the expression occurs prominently in the developing lens. Hedgehog signaling is required for the Lc3 synthase expression in embryonic lens
brenda
intestinal
brenda
-
brenda
the primary lymphoid organs
brenda
vascular mesenchyme of the embryo
brenda
-
-
brenda
-
brenda
-
brenda
-
brenda
Notum1a is expressed in the lateral edges and midline of the posterior neural plate. During segmentation, it is expressed in stripes at the lateral edges and adjacent to the midline of the neural plate
brenda
-
brenda
-
-
brenda
-
brenda
-
-
brenda
CCP1 and CCP5 mRNAs are predominantly expressed in tissues such as the brain, olfactory placodes, and pronephric ducts
brenda
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
expression appears to be constitutive. No significant difference is noticed in the level of expression among follicles of different stages. Treatment of cultured ovarian follicle cells with gonadotropin and activin has little effect on the expression of the enzyme
brenda
highest level of enzyme present in ova and brain
brenda
-
brenda
-
brenda
at 24 h after fertilization, endothelial cells of the pharyngeal arch vasculature
brenda
three membrane bound sensory guanylate cyclases, from developing and adult zebrafish retina
brenda
-
brenda
of 36-h post-fertilization zebrafish embryos
brenda
-
brenda
-
brenda
-
-
brenda
-
specific smooth muscle isozyme smMLCK encoded by gene MLCK2
brenda
low level of expression
brenda
-
-
brenda
-
brenda
-
brenda
embryo
brenda
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
brenda
in all tissues
brenda
-
-
brenda
cpn1 mRNA is expressed in developing vessels of the embryo
brenda
A1XRK1, A8E7C8, B0UYE4, B8XY54, B8XY55, B8XY56, E7F6G2, F1QRQ5, O13146, Q08CT3, Q1LUX8, Q29RD8, Q568I9, Q5RHM1, Q5RKM1, Q6GQM2, Q6NSN2, Q6P0K4, Q6TS32, Q6YI49, Q75W66, Q7T2P7, Q7T3S3, Q7ZVF2
-
490040, 663827, 664650, 669275, 673249, 682108, 682138, 682907, 682918, 683206, 686286, 697462, 702127, 703291, 703488, 707879, 710619, 713127, 716777, 718096, 720540, 721074, 722565, 727337, 727949, 729213, 729759, 732365, 735999, 737100, 738389, 739153, 750564, 750712, 758142
brenda
13cIMH expression is detected in the periventricular grey zone of the optic tectum and torus longitudinalis, at the fasciculus longitudinalis medialis in the medulla oblongata, and at the periventricular pretectum
brenda
-
24hpf embryos
brenda
adult
brenda
-
Capn5 is strongly expressed in the developing embryonic brain, early optic vesicles, and in newly differentiated retinal photoreceptors
brenda
CCP1 and CCP5 mRNAs are predominantly expressed in tissues such as the brain, olfactory placodes, and pronephric ducts
brenda
discreetly expressed, lower levels of transcript variant ACOX1-3I, the ACOX1-3I transcript variant is expressed seven times less in brain than the ACOX1-3II variant
brenda
discreetly expressed, lower levels of transcript variant ACOX13II, the ACOX13II transcript variant is expressed seven times more in brain than the ACOX13I variant
brenda
dopaminergic cell clusters have low to moderate levels of MAO activity. The highest levels of MAO activity are detected in noradrenergic and serotonergic cell groups and the habenulointerpeduncular pathway, including its caudal projection to the medial ventral rhombencephalon
brenda
during the pharyngula stage, expression is restricted to the brain
brenda
embryo, developing brain. The enzyme is moderately expressed in a cell cluster restricted to the forebrain and hindbrain with a clearer and more intense signal in the otic vesicles
brenda
expression analysis
brenda
expression detected by RT-PCR
brenda
GRK7-2, almost exclusively in the brain
brenda
-
high expression
brenda
high expression level in embryonic brain
brenda
-
high expression of isoforms Gstz1, Gstp, Gstm, Gstr1, Mgst3a, and Mgst3b
brenda
highest expression in muscle and brain
brenda
highest expression level of isozyme pentraxin-carbonic anhydrase
brenda
highest level of enzyme present in ova and brain
brenda
-
highly expressed
brenda
-
low activity in both sexes
brenda
-
MAO expression and activity are located in or adjacent to serotonergic nuclei and their targets especially in the ventral hypothalamus
brenda
midbrain and hindbrain
brenda
midbrain-hindbrain boundary
brenda
of embryo
brenda
strong expression
brenda
-
the enzyme is predominantly expressed in brain
brenda
-
brenda
at 24 h post fertilization, expression is particularly pronounced in the central nervous system, including the dorsal neural tube and the midbrain-hindbrain boundary
brenda
expression analysis
brenda
robust expression in the entire central nervous system, the somites, the notochord, and the developing pronephric duct
brenda
-
-
brenda
diencephalic catecholaminergic cluster and locus caeruleus of 36-h post-fertilization zebrafish embryos
brenda
-
brenda
very low expression level of isozyme pentraxin-carbonic anhydrase
brenda
A0JMD1, A1A5H8, A1L1V4, A4U7F8, A4U7F9, A6MH29, A6MH32, A6MH33, A6MH34, A6MH35, A8E7C8, A9YD19, B3DKP9, B8A5U5, C5H5C4, E7F6G2, F1QPV1, F1QQC3, O73791, Q0H2G3, Q1KHF8, Q1KHF9, Q2TL58, Q4LEU0, Q561X9, Q5GA10, Q5GA12, Q5RGL8, Q5RHM1, Q6DRN0, Q6IQS4, Q6NY97, Q6NYT8, Q75W66, Q7SXK1, Q7T322, Q7T3S3, Q803C3, Q805E5, Q9PTF3, U3JB00
-
286462, 490046, 657538, 661555, 673107, 673243, 673851, 675068, 675767, 675900, 676750, 676954, 679161, 679416, 679687, 680835, 686283, 686297, 686831, 688797, 692481, 693160, 697534, 702127, 702312, 702887, 703238, 703374, 703376, 704792, 707369, 708280, 708586, 710342, 711587, 713377, 713538, 717428, 720809, 723634, 723815, 731714, 732133, 733700, 734356, 735999, 736091, 738093, 738389, 738625, 738938, 739410, 739558, 740793, 749050, 752649, 753919, 755462, 755549, 758111, 761483, 762457
brenda
abundant expression at early stage, with an abrupt decrease after 3 days postfertilization
brenda
acox1 transcripts diffusely distributed in early-stage embryonic cells
brenda
-
at 11.5 h of development, cdk5 transcripts are present in the neural plate at the domains where primary neurons begin to be specified
brenda
-
at different developmental stages, expression pattern, overview
brenda
-
at the segmentation period, at 12, 18 and 48 h after fertilization
brenda
-
bcdo2 is expressed in the developing zebrafish
brenda
both isoforms SOAT1 and SOAT2 express in the yolk syncytial layer, hatching gland and developing cardiovascular as well as digestive systems
brenda
-
casp8 is maternally expressed, and transcripts continue to be present throughout embryogenesis and into larval stages
brenda
-
during embryogenesis the enzyme is present from the sphere stage until hatching
brenda
-
endogenous expression pattern of top2a during development, overview
brenda
-
enzyme activity at different developmental stages, overview
brenda
enzyme expression during embryogenesis from sphere to 84 h post-fertilization
brenda
epiphysis, locus caeruleus, diencephalic catecholaminergic clusters, and raphe nuclei of 36-h post-fertilization zebrafish embryos
brenda
expression detected by RT-PCR
brenda
-
first 48 h post-fertilization
brenda
high expression level in embryonic brain
brenda
IDS activity already detected at the 64-cell stage, and increases at 6.5 hours post fertilization, during the onset of gastrulation. A gradual decrease of enzymatic activity from 24 hours post fertilization to 5 dpf
brenda
in all tissues
brenda
-
knock-down of dihydrofolate reductase or heart and neural crest derivatives expressed transcript HAND2 in fertilized eggs causes cardiac malformation. Expression of HAND2 is reduced in dihydrofolate reductase knock-down embryos. Microinjection of HAND2 mRNA into fertilized eggs can induce HAND2 overexpression which rescues the cardiac malformation phenotypes of dihydrofolate knock-down embryos
brenda
low level of expression in the segmentation period during the embryonic development
brenda
-
present in early embryos up to the 1000-cell stage as a maternal factor, and is then expressed throughout the body after the gastrula stage by zygotic expression
brenda
-
significant level of expression at the beginning of the hatching period during embryogenesis, enzyme form SULT1 ST5
brenda
spatiotemporal expression of gene uch-L1 mRNA during embryo development
brenda
-
th enzyme is expressed throughout the whole embryonic development
brenda
-
the aryl amide/acetylcholinesterase ratio decreases 210fold from 4 to 144 hours of development, developmental expression analysis
brenda
the enzyme is expressed in two distinct phases during the zebrafish embryogenesis. The early phase extends from late blastulation to the completion of epiboly, during which the expression occurs in the superficial layer of the embryos. The second phase of expression starts during mid-segmentation and persists until day 3, during which the expression occurs prominently in the developing lens
brenda
-
the enzyme is maternally loaded and expressed throughout development, overview
brenda
weakly expressed in the embryo at 48 and 72 hours post-fertilization stages, and strongly expressed in the embryo at 96 hours post-fertilization stage
brenda
-
wide expression pattern for isoforms Cbsa and Cbsb primarily along the embryonic axis of the developing embryo
brenda
-
brenda
-
enzyme expression in developing basal layer of the epidermis, enzyme inactivation by HAI-1 is required for epithelial integrity of the zebrafish epidermis, overview
brenda
-
brenda
-
especially in the lens capsule of 24hpf embryos
brenda
-
expressed
brenda
intermediate expression level
brenda
intermediate level of expresssion
brenda
larval and adult eyes
brenda
lens
brenda
-
low expression
brenda
low level of RNase Dre1
brenda
raldh3 mRNA is first expressed in the developing eye region of zebrafish embryos at 10-somite stage. At 24 hpf (hours post fertilization), raldh3 mRNA is expressed in the ventral retina of eye. At 36 hpf, the mRNA is also expressed in otic vesicle in addition to ventral retina, and it maintains its expression pattern till 2 dpf (days post fertilization). At 3 dpf, raldh3 mRNA becomes very weak in ventral retina but is present in otic vesicle at a high level. At 5 dpf and 7 dpf, raldh3 is no longer expressed in eyes but is expressed in otic vesicles at a very low level
brenda
strong expression
brenda
weak expression
brenda
-
brenda
-
basement membrane
brenda
high expression level of isozyme pentraxin-carbonic anhydrase
brenda
pectoral
brenda
pectoral and median
brenda
-
absent from Müller glia
brenda
-
axons and dendrites
brenda
-
brenda
-
high expression
brenda
-
high expression of isoforms Gsto2, Gstp, Gstm, Gstr1, Mgst3a, and Mgst3b
brenda
low expression level
brenda
-
-
brenda
during development all zebrafish males first develop a juvenile ovary, that later degenerates and transforms into a testis, the enzyme is involved, but not inducing, in gonadal transformation in the zebrafish, but its localization is not related to the position of degenerating oocytes, overview
brenda
-
high expression
brenda
-
brenda
embryo and adult
brenda
strong expression
brenda
-
brenda
embryo
brenda
-
zMoz expression is restricted to the zebrafish head
brenda
-
brenda
adult
brenda
elevated mRNA expression detected by RT-PCT
brenda
-
expression in male, hardly detectable in female
brenda
high expression within developing heart
brenda
-
highly expressed
brenda
-
knock-down of dihydrofolate reductase or heart and neural crest derivatives expressed transcript HAND2 in fertilized eggs causes cardiac malformation
brenda
-
Na+K+-ATPase activity is positively regulated via an N-terminal phosphorylation site that is necessary for correct heart morphogenesis to occur, and maintenance of Zonula occludens-1 junction belts requires ion pump activity
brenda
-
specific cardiac/ventricular isozyme cardiac-MLCK
brenda
very low expression level of isozyme pentraxin-carbonic anhydrase
brenda
weak expression
brenda
Q6DEJ9 and Q561S6 and Q1LXA2
-
brenda
embryo
brenda
-
isoform lunatic fringe Lfng is expressed by progenitors in neurogenic regions and downregulated in cells that have initiated neuronal differentiation
brenda
-
-
brenda
-
MAO expression and activity are located in or adjacent to serotonergic nuclei and their targets especially in the ventral hypothalamus
brenda
-
brenda
a strong signal for neutral CDase is detected in zebrafish intestine at the luminal surface of the villi and microvilli of adsorptive epithelial cells
brenda
and the tissue around the intestine
brenda
expression detected by RT-PCR
brenda
-
expression in male, hardly detectable in female
brenda
-
high expression
brenda
-
high expression of isoforms Gsta, Gstp, Gstm, Gstr1, Mgst3a, and Mgst3b
brenda
intestine and the tissue around the intestine
brenda
-
prominent expression in intestine
brenda
raldh4 mRNA is present in developing intestine regions at 2 dpf embryos. Its expression level becomes very high in embryos from 3 dpf to 5 dpf. In 5 dpf embryos raldh4 is expressed in the epithelium of intestine. At 7 dpf, raldh4 mRNA is only weakly expressed in the epithelium of intestinal bulb
brenda
very low expression level of isozyme pentraxin-carbonic anhydrase
brenda
widely present at later stages, high levels of transcript variant ACOX13II in the anterior intestine, significant pretranslational up-regulation of acox1 expression in the anterior intestine after feeding
brenda
widely present at later stages, high levels of transcript variants ACOX1-3I in the anterior intestine, significant pretranslational up-regulation of acox1 expression in the anterior intestine after feeding
brenda
A0A097HUX0, A1XRK1, E7F742, F1QRQ5, Q08CT3, Q1LUX8, Q5RHM1, Q5RKM1, Q6GQM2, Q7T2P7, Q7ZVF2
-
655669, 683206, 686286, 703291, 718096, 721074, 727337, 737100, 737985, 748840, 750712
brenda
-
expression in male, hardly detectable in female
brenda
-
high expression
brenda
-
high expression of isoforms Gstz1, Gstp, Gstm, Gstr1, Mgst3a, and Mgst3b
brenda
pronephros and mesonephros
brenda
A0A097HUX0, A0A1D5NSI1, A8E7C8, B8A5U5, E7F6G2, F1R440, Q49HM8, Q49HM9, Q4QRE2, Q5RGL8, Q6DRN0, Q7T3B8, Q7ZWE2, Q803T5, Q8JH28
-
666451, 676339, 697545, 708077, 714804, 731928, 732122, 735797, 735999, 736677, 737985, 744984, 747961, 749050, 758111
brenda
-
casp8 is maternally expressed, and transcripts continue to be present throughout embryogenesis and into larval stages
brenda
-
development of MAO expression follows a similar time course as the serotonin system
brenda
-
gradual increase in expression to a high level of expression throughout the larval stage of maturity, enzyme form SULT1 ST5
brenda
high level expression throughout the larval stage onto maturity
brenda
A0A1D8GR35, A1XRK1, A7MD59, B0UXS0, B0UYE4, B8XY54, B8XY55, B8XY56, E7F079, F1QRQ5, Q08CT3, Q1LUX8, Q5BLE8, Q5RHM1, Q5RKM1, Q6GQM2, Q7T2P7, Q7ZVF2, Q803C3
-
669905, 672228, 683206, 686286, 697534, 703291, 704524, 705695, 707879, 718096, 727337, 729759, 737100, 743204, 746533, 750712, 758142
brenda
elevated mRNA expression detected by RT-PCT. Strong protein expression detected by western blotting
brenda
embryo
brenda
-
expressed
brenda
-
high expression
brenda
-
high expression of isoforms Gstt1a, Gstz1, Gstp, Gstr1, Mgst3a, and Mgst3b
brenda
highest enzyme expression in male liver
brenda
highly expressed in liver
brenda
intermediate expression level
brenda
-
most prominent expression in liver
brenda
of embryo
brenda
raldh4 mRNA is present in developing liver regions at 2 dpf embryos. Its expression level becomes very high in embryos from 3 dpf to 5 dpf
brenda
siginificant protein expression detected by Western Blotting only in liver and ovary
brenda
strong expression
brenda
very low expression level of isozyme pentraxin-carbonic anhydrase
brenda
widely present at later stages, high levels of transcript variant ACOX1-3I
brenda
widely present at later stages, high levels of transcript variant ACOX13II
brenda
Q6DEJ9 and Q561S6 and Q1LXA2
-
brenda
embryo
brenda
-
brenda
-
24hpf embryos
brenda
adult
brenda
higher enzyme expression level
brenda
highest expression in muscle and brain
brenda
-
-
brenda
-
NFS is primarily expressed in the developing nervous system. At the 14 somite stage, nsf is expressed within cells of the developing trigeminal ganglia, anterior spinal cord, and forebrain. At 20 somites, transcripts are detectable in additional cranial ganglia and throughout the length of the developing spinal cord. By 30 hours post-fertilization, nsf is also visible in regions of the developing midbrain and hindbrain and in the posterior lateral line ganglia. At 48 hours post-fertilization, expression persistes in spinal cord and is present throughout mots of the developing brain and eyes, while at 72 hours post-fertilization, spinal cord expression is less evident. Expression in the posterior lateral line ganglia persists to at least 72 hours post-fertilization
brenda
-
brenda
-
peripheral, acetyl-K40 alpha-tubulin is enriched in cilia and axons of neurons
brenda
A1L1V4, A6MH29, A6MH32, A6MH33, A6MH34, A6MH35, A8E7C8, E7F6G2, F1QQC3, Q6NYT8, Q75W66, Q7T3S3, Q805E5
-
brenda
of embryo
brenda
robust expression in the entire central nervous system, the somites, the notochord, and the developing pronephric duct
brenda
-
brenda
adult
brenda
elevated mRNA expression detected by RT-PCT. Strong protein expression detected by western blotting
brenda
-
expressed in follicle cells
brenda
expression detected by RT-PCR
brenda
-
high expression of isoforms Gsto2, Gstp, Gstm, Gstr1, Mgst3a, and Mgst3b
brenda
highest enzyme expression in female ovaries
brenda
highly expressed
brenda
low level of RNase Dre1
brenda
siginificant protein expression detected by Western Blotting only in liver and ovary
brenda
-
brenda
of embryo
brenda
very low expression level of isozyme pentraxin-carbonic anhydrase
brenda
-
brenda
-
photoreceptor segments, NTPDases 1 and 2 differentially localized in
brenda
-
-
brenda
GRK1B and GRK7-2 are the dominant subtypes
brenda
-
brenda
CCP1 and CCP5 mRNAs are predominantly expressed in tissues such as the brain, olfactory placodes, and pronephric ducts
brenda
-
brenda
pronephric duct of embryo
brenda
-
brenda
-
Capn5 is strongly expressed in the developing embryonic brain, early optic vesicles, and in newly differentiated retinal photoreceptors. Expression of Capn5 colocalizes with cone-specific markers in the adult zebrafish retina
brenda
embryo
brenda
-
inner
brenda
of embryo
brenda
-
optic nerve regenerating retinas
brenda
rods and cones
brenda
three membrane-bound sensory guanylate cyclases expressed in photoreceptor cells of the developing and adult zebrafish retina, expression analysis, overview
brenda
-
type 1 membrane-bound guanylate cyclase is expressed exclusively in the retina
brenda
outer segment
brenda
outer segment GRK1-homologue GRK7a
brenda
outer segment GRK1-homologue GRK7b
brenda
-
PDE6alpha' is expressed exclusively in cone photoreceptors, its activity is important for the survival of cone photoreceptors
brenda
A0A2R8QKI3, Q6DRN0, Q9PW76 AND Q6PBW6 AND Q7T2P2 AND Q6P123 AND Q6NVI6 AND E9QGU4 AND B3DKJ0 AND A0A0R4IJT8
-
brenda
-
highly expressed
brenda
-
localization to the myotendinous junction (MTJ), laminin is necessary to recruit/retain Mmp11 at the MTJ. Mmp11 is strongly expressed at the MTJ in zebrafish at 2 days post fertilization. Mmp11 expression throughout primary muscle development
brenda
-
brenda
-
expression in male, hardly detectable in female
brenda
low expression level
brenda
low level of RNase Dre1
brenda
very low expression level of isozyme pentraxin-carbonic anhydrase
brenda
-
brenda
enzyme is weakly expressed during nervous system development, and shows a highly dynamic expression pattern in somites and somite-derived structures
brenda
robust expression in the entire central nervous system, the somites, the notochord, and the developing pronephric duct
brenda
-
brenda
-
24hpf embryos
brenda
-
brenda
-
expression in male, hardly detectable in female
brenda
intermediate level of expresssion
brenda
very low expression level of isozyme pentraxin-carbonic anhydrase
brenda
-
expressed
brenda
very low expression level of isozyme pentraxin-carbonic anhydrase
brenda
-
brenda
-
high expression of isoforms Gsta, Gstp, Gstm, Gstr1, Mgst3a, and Mgst3b
brenda
very high expression level
brenda
intermediate expression level
brenda
intermediate level of expresssion
brenda
-
-
brenda
-
main localization
brenda
additional information
almost no expression in brain, heart, intestine, and testis
brenda
additional information
both isoforms Dio3a and Dio3b are expressed during development and both contribute to in vivo type 3 iodothyronine deiodinase activity
brenda
additional information
-
broad expression pattern for meprins
brenda
additional information
C4ST-1 expression pattern, overview
brenda
additional information
-
developmental expression analysis of the 3-OST gene family, mRNA expression patterns in several tissues/organs throughout early zebrafish development, including early cleavage stages, somites, brain, internal body organ primordial, and pectoral fin development, overview
brenda
additional information
-
during fish developement, top2b mRNA is broadly expressed at early stages and becomes restricted to the central nervous system later. Noto heterozygotes in the TL strain are crossed with fish from the highly polymorphic WIK strain, and adult TL/WIK noto heterozygotes are bred repeatedly to generate TL/WIK recombinant wild-type and mutant larvae
brenda
additional information
-
dynamic expression pattern of pld1 during early zebrafish development, overview
brenda
additional information
embryonic otic vesicle, splanchnocranium and pectoral fin bud
brenda
additional information
-
enzyme homologue RPE65c is expressed in retinal Müller cells, not in the retinal pigment epithelium. Zebrafish is a cone-dominant species with 79% cones and 21% rods
brenda
additional information
enzyme is active at all stages of egg and embryo development
brenda
additional information
enzyme is expressed in yolk syncytial layer and various embryonic tissues such as notochord, brain, retina, pronephric duct, liver, and pancreas
brenda
additional information
expression in female and male tissues, sexual dimorphism, no activity in zf4 cells
brenda
additional information
gene csgalnact1 expression analysis during fish development, in situ immunohistochemic analysis, overview. Gene csgalnact1 mRNA is not maternally deposited, instead a rather weak and ubiquitous expression is seen during early somitogenesis. At 24 hr post fertilization, gene csgalnact1 expression is mostly restricted to the notochord and to the otic capsule, but weak staining is also seen in the intermediate cell mass, a hematopoietic region at this stage. At later stages, csgalnact1 expression becomes restricted mainly to cartilage structures, and the regions of the pharyngeal arches, the otic capsule, the pectoral fins, the notochord, and the median fin fold. At 72 hr post fertilization, weak staining in brain tissue and the spinal cord appears, while strong staining is detected in cartilage structures and the brain ventricular zone
brenda
additional information
gene csgalnact2 expression analysis during fish development, in situ immunohistochemic analysis, overview. The csgalnact2 probe strongly stains embryos already at the 2-cell stage indicating maternally deposited mRNA. Notochord staining is visible already from the 5-somite stage and expression is apparent at the 15-somite stage in the tail bud and in the notochord, whereas the expression at 24 hr post fertilization is restricted to the brain tissue and the posterior region of the somites and the notochord. Expression is further detected in brain tissue at 36 and 48 hr post fertilization when staining appeared also in the pectoral fins, the notochord, the otic capsule, and cartilage structures. By 72 hr post fertilization, expression is restricted to the head, the spinal cord, and the pronephric ducts
brenda
additional information
genes ssat1a, ssat1b, and ssat1c ares ubiquitously expressed in fish tissues st different levels, expression patterns, overview
brenda
additional information
hatchling
brenda
additional information
immunohistochemic analysis of enzyme distribution in zebrafish tissues, quantitative expression analysis of ca6 mRNA in wild-type and the ca6 morphant zebrafish at different stages of development
brenda
additional information
-
in adult tissues 20beta-HSD type 2 shows a ubiquitous expression pattern with some minor sex-specific differences
brenda
additional information
-
in adult tissues, isoform 20beta-HSD type 2 shows a ubiquitous expression pattern with some minor sex-specific differences
brenda
additional information
-
intermediate cell mass
brenda
additional information
isoform PRMT1 transcripts are detected from the zygote period to the early larva stage
brenda
additional information
isoform Prps1b displays a low level of expression at 1 hour post fertilization. A dramatic increase of expression is detected from 5 h post fertilization. The expression decreases and is maintained at a lower level until at 40 days post fertilization as the fish enter a juvenile age
brenda
additional information
isoform Prps1b displays a modest change in the level of expression with the highest expression detected at 1 h post fertilization and a lower level present and maintained at other ages
brenda
additional information
isoform RPE65c is not detected in the retinal pigment epithelium
brenda
additional information
isoform SOAT1 is ubiquitously expressed
brenda
additional information
isozyme expression analysis, overview
brenda
additional information
isozymes GPBP and GPBPDELTA26 are differentially expressed during development, isozymes function during embryogenesis, GPBP is an important factor for normal skeletal muscle and brain development, overview
brenda
additional information
isozymes GPBP and GPBPDELTA26 are differentially expressed during development, isozymes function during embryogenesis, overview
brenda
additional information
MnSOD developmental expression, overview
brenda
additional information
not detected in skeletal muscle, liver, or kidney
brenda
additional information
-
not expressed in the embryonic notochord
brenda
additional information
Prmt7 transcripts and protein are maternally deposited and ubiquitously expressed through gastrulation
brenda
additional information
RNase Dre1 is absent from liver
brenda
additional information
-
rnaset2 is expressed ubiquitously in zebrafish embryos and adults from conception
brenda
additional information
RT-PCR results show that zmSHMT mRNA is evenly distributed among tissues. However zmSHMT protein expression does not correspond to the detected mRNA expression detected in most tissues
brenda
additional information
the enzyme is ubiquitously expressed and evident already during the early development, enzyme expression during the first week of fish development and in several tissues, overview
brenda
additional information
-
the enzyme is universally expressed in zebrafish tissues
brenda
additional information
the mRNA of cyp11b is detected in all the adult organs tested
brenda
additional information
tissue-specific regulation of uhc-L1 gene expression, analysis, overview
brenda
additional information
ubiquitous expression with especially strong staining in brain and eye
brenda
additional information
-
zebrafish ext2 gene is ubiquitously expressed during zebrafish development
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.